primaryid$caseid$caseversion$i_f_code$event_dt$mfr_dt$init_fda_dt$fda_dt$rept_cod$auth_num$mfr_num$mfr_sndr$lit_ref$age$age_cod$age_grp$sex$e_sub$wt$wt_cod$rept_dt$to_mfr$occp_cod$reporter_country$occr_country
100036412$10003641$2$F$201304$20140416$20140312$20150312$PER$$US-ABBVIE-13P-163-1090373-00$ABBVIE$$41$YR$$M$Y$118.04$KG$20150312$N$CN$US$US
100038593$10003859$3$F$20130717$20141210$20140312$20150312$PER$$US-INCYTE CORPORATION-2013IN001676$INCYTE$$63$YR$$M$Y$92.06$KG$20150312$N$CN$US$US
100038603$10003860$3$F$200807$20150319$20140312$20150331$EXP$$US-BAYER-2014-035493$BAYER$$25$YR$A$F$Y$49.89$KG$20150331$N$CN$US$US
100039823$10003982$3$F$20130701$20140325$20140312$20150122$EXP$$US-INCYTE CORPORATION-2014IN000187$INCYTE$$79$YR$$M$Y$$$20150122$N$CN$US$US
100039882$10003988$2$F$201310$20140811$20140312$20150312$PER$$US-ABBVIE-13P-163-1177683-00$ABBVIE$$43$YR$$F$Y$54.48$KG$20150312$N$CN$US$US
100039973$10003997$3$F$20131230$20141120$20140312$20150312$PER$$US-INCYTE CORPORATION-2014IN000035$INCYTE$$80$YR$$F$Y$63.04$KG$20150312$N$CN$US$US
100040603$10004060$3$F$200801$20150317$20140312$20150327$PER$$US-BAYER-2014-036236$BAYER$$33$YR$A$F$Y$68.27$KG$20150327$N$LW$US$US
100040674$10004067$4$F$201110$20150317$20140312$20150327$PER$$US-BAYER-2014-036172$BAYER$$40$YR$A$F$Y$56.69$KG$20150327$N$CN$US$US
100041104$10004110$4$F$20120723$20141222$20140312$20150105$EXP$$PHHY2014CA028965$NOVARTIS$$40$YR$$M$Y$$$20150106$N$CN$COUNTRY NOT SPECIFIED$CA
100041203$10004120$3$F$20140117$20150316$20140312$20150317$EXP$$PHHO2014PL003565$NOVARTIS$$61$YR$$M$Y$74$KG$20150317$N$MD$PL$PL
100041412$10004141$2$F$$20150223$20140312$20150310$EXP$$PHEH2014US004840$NOVARTIS$$$$$M$Y$76$KG$20150310$N$OT$US$US
100042853$10004285$3$F$20131018$20150106$20140312$20150117$EXP$$PHEH2014US004853$NOVARTIS$$54$YR$$F$Y$$$20150118$N$CN$COUNTRY NOT SPECIFIED$US
100043563$10004356$3$F$201308$20141231$20140312$20150105$EXP$FR-ANSM-PC20140097$FR-GILEAD-2014-0096403$GILEAD$$30$YR$A$F$Y$$$20150105$N$OT$FR$FR
100046723$10004672$3$F$$20150122$20140312$20150130$PER$$US-ALEXION-A200800605$ALEXION$$$$$$Y$$$20150130$N$OT$US$US
100047183$10004718$3$F$20150122$20150128$20140312$20150211$EXP$$US-GLAXOSMITHKLINE-A1063571A$GLAXOSMITHKLINE$$64$YR$$F$Y$$$20150211$N$CN$US$US
100048205$10004820$5$F$$20150303$20140312$20150313$EXP$$US-PFIZER INC-2014029927$PFIZER$$68$YR$$F$Y$$$20150313$N$MD$US$US
100049264$10004926$4$F$2007$20150205$20140312$20150213$PER$$US-BAYER-2014-037244$BAYER$$20$YR$A$F$Y$54$KG$20150213$N$OT$US$US
100052073$10005207$3$F$2013$20141208$20140312$20150312$PER$$US-INCYTE CORPORATION-2013IN002940$INCYTE$$$$$M$Y$73.02$KG$20150312$N$CN$US$US
100052233$10005223$3$F$20140124$20140505$20140312$20150219$PER$$US-ABBVIE-14P-163-1209028-00$ABBVIE$$60$YR$$F$Y$$$20150219$N$MD$COUNTRY NOT SPECIFIED$US
100053783$10005378$3$F$20130528$20150209$20140313$20150217$EXP$$BR-ROCHE-1231872$ROCHE$$20$YR$$F$Y$$$20150217$N$PH$BR$BR
100054492$10005449$2$F$$20140307$20140313$20150324$EXP$$CO-ROCHE-1363980$ROCHE$$$$$M$Y$$$20150325$N$CN$CO$CO
100055442$10005544$2$F$$20140304$20140313$20150129$EXP$$US-ROCHE-1359743$ROCHE$$$$$F$Y$96.25$KG$20150129$N$MD$US$US
100059053$10005905$3$F$20100122$20150317$20140313$20150325$PER$$US-BAYER-2014-035392$BAYER$$25$YR$A$F$Y$56.69$KG$20150325$N$CN$US$US
100059802$10005980$2$F$$20150210$20140313$20150221$PER$$GB-JNJFOC-20140303743$MCNEIL$$$$$F$Y$$$20150221$N$MD$GB$GB
100060582$10006058$2$F$20130926$20150213$20140313$20150226$EXP$$SE-JNJFOC-20140306223$JANSSEN$$71$YR$E$F$Y$$$20150226$N$MD$SE$SE
100062032$10006203$2$F$2013$20150313$20140313$20150331$EXP$$US-ASTELLAS-2014US002488$ASTELLAS$$85$YR$$M$Y$$$20150330$N$CN$GB$US
100063443$10006344$3$F$20090818$20150317$20140313$20150323$EXP$$HK-SA-2014SA029034$AVENTIS$$62$YR$A$M$Y$51$KG$20150323$N$MD$HK$HK
100063614$10006361$4$F$2010$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014068387$PFIZER$$73$YR$$F$Y$54$KG$20150130$N$LW$US$US
100063625$10006362$5$F$2000$20150129$20140313$20150205$EXP$$US-PFIZER INC-2014068372$PFIZER$$44$YR$$F$Y$58$KG$20150205$N$LW$US$US
100063674$10006367$4$F$20110302$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068096$PFIZER$$69$YR$$F$Y$73$KG$20150217$N$LW$US$US
100063744$10006374$4$F$200606$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068416$PFIZER$$54$YR$$F$Y$$$20150217$N$LW$US$US
100063765$10006376$5$F$200612$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014068420$PFIZER$$55$YR$$F$Y$100$KG$20150113$N$LW$US$US
100063855$10006385$5$F$200910$20150107$20140313$20150109$EXP$$US-PFIZER INC-2014066549$PFIZER$$68$YR$$F$Y$63$KG$20150109$N$LW$US$US
100063926$10006392$6$F$200408$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014068418$PFIZER$$77$YR$$F$Y$66$KG$20150113$N$LW$US$US
100063946$10006394$6$F$20051020$20150225$20140313$20150227$EXP$$US-PFIZER INC-2014068388$PFIZER$$48$YR$$F$Y$57$KG$20150227$N$LW$US$US
100064314$10006431$4$F$201207$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014068405$PFIZER$$54$YR$$F$Y$72.5$KG$20150202$N$LW$US$US
100064328$10006432$8$F$20131129$20150219$20140313$20150220$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-08802NB$BOEHRINGER INGELHEIM$$87$YR$$M$Y$56.1$KG$20150221$N$MD$JP$JP
100064803$10006480$3$F$$20140227$20140313$20140313$EXP$$CA-ARROW-2012-17806$ACTAVIS$$$$$$Y$$$20140313$N$CN$CA$CA
100064835$10006483$5$F$20070709$20150209$20140313$20150216$EXP$$US-PFIZER INC-2014066567$PFIZER$$67$YR$$F$Y$61.22$KG$20150216$N$LW$US$US
100064844$10006484$4$F$200411$20150213$20140313$20150220$EXP$$US-PFIZER INC-2014066628$PFIZER$$47$YR$$F$Y$$$20150220$N$LW$US$US
100064865$10006486$5$F$2006$20150209$20140313$20150213$EXP$$US-PFIZER INC-2014066423$PFIZER$$48$YR$$F$Y$84$KG$20150213$N$LW$US$US
100064874$10006487$4$F$20030502$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014066404$PFIZER$$65$YR$$F$Y$$$20150113$N$LW$US$US
100064893$10006489$3$F$2011$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014066353$PFIZER$$60$YR$$F$Y$62$KG$20150113$N$LW$US$US
100064904$10006490$4$F$200610$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014066566$PFIZER$$65$YR$$F$Y$$$20150113$N$LW$US$US
100064915$10006491$5$F$2005$20150209$20140313$20150212$EXP$$US-PFIZER INC-2014066565$PFIZER$$50$YR$$F$Y$72$KG$20150212$N$LW$US$US
100065505$10006550$5$F$20121219$20150127$20140313$20150129$EXP$$US-PFIZER INC-2014066691$PFIZER$$56$YR$$F$Y$73$KG$20150129$N$LW$US$US
100065535$10006553$5$F$2004$20150209$20140313$20150216$EXP$$US-PFIZER INC-2014066684$PFIZER$$59$YR$$F$Y$70$KG$20150216$N$LW$US$US
100065605$10006560$5$F$20121211$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014066719$PFIZER$$59$YR$$F$Y$68$KG$20150217$N$LW$US$US
100065615$10006561$5$F$1998$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068401$PFIZER$$45$YR$$F$Y$61$KG$20150217$N$LW$US$US
100065635$10006563$5$F$2010$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068414$PFIZER$$53$YR$$F$Y$54$KG$20150217$N$LW$US$US
100065645$10006564$5$F$201010$20150107$20140313$20150113$EXP$$US-PFIZER INC-2014066413$PFIZER$$76$YR$$F$Y$$$20150113$N$LW$US$US
100065654$10006565$4$F$200608$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014066717$PFIZER$$65$YR$$F$Y$$$20150202$N$LW$US$US
100065724$10006572$4$F$2010$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014066570$PFIZER$$57$YR$$F$Y$$$20150130$N$LW$US$US
100065795$10006579$5$F$2010$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014066693$PFIZER$$51$YR$$F$Y$112$KG$20150217$N$LW$US$US
100065804$10006580$4$F$20091116$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014066629$PFIZER$$46$YR$$F$Y$$$20150202$N$LW$US$US
100065904$10006590$4$F$20140215$20150107$20140313$20150115$EXP$$US-ACTELION-A-US2010-33272$ACTELION$$49$YR$A$F$Y$$$20150116$N$PH$US$US
100065986$10006598$6$F$20140120$20150312$20140313$20150320$EXP$$CA-JNJFOC-20140114894$JANSSEN$$44$YR$A$F$Y$69.5$KG$20150320$N$CN$CA$CA
100066473$10006647$3$F$$20150304$20140313$20150312$EXP$$US-PFIZER INC-2014070566$PFIZER$$36$YR$$F$Y$$$20150312$N$OT$US$US
100071256$10007125$6$F$2009$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014069865$PFIZER$$58$YR$$F$Y$91$KG$20150130$N$LW$US$US
1000713215$10007132$15$F$20140301$20150323$20140313$20150327$EXP$$US-PFIZER INC-2014070491$PFIZER$$76$YR$$M$Y$$$20150327$N$LW$US$US
100071423$10007142$3$F$2001$20141230$20140313$20150105$EXP$$US-PFIZER INC-2014063238$PFIZER$$60$YR$$F$Y$59$KG$20150105$N$LW$US$US
100071584$10007158$4$F$200708$20141229$20140313$20150102$EXP$$US-PFIZER INC-2014069863$PFIZER$$74$YR$$F$Y$67$KG$20150102$N$LW$US$US
100071884$10007188$4$F$20070914$20150226$20140313$20150304$EXP$$US-PFIZER INC-2014066456$PFIZER$$49$YR$$F$Y$89$KG$20150304$N$LW$US$US
100072523$10007252$3$F$$20150205$20140313$20150211$EXP$$US-SA-2014SA028058$AVENTIS$$61$YR$A$F$Y$$$20150211$N$CN$US$US
100074446$10007444$6$F$$20150316$20140313$20150324$PER$$US-PFIZER INC-2014042819$PFIZER$$61$YR$$F$Y$59$KG$20150324$N$CN$US$US
100074604$10007460$4$F$201207$20150213$20140313$20150223$EXP$$US-PFIZER INC-2014069890$PFIZER$$52$YR$$F$Y$90$KG$20150223$N$LW$US$US
100074774$10007477$4$F$200504$20150107$20140313$20150109$EXP$$US-PFIZER INC-2014069938$PFIZER$$48$YR$$F$Y$$$20150109$N$LW$US$US
100074785$10007478$5$F$2004$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014068375$PFIZER$$55$YR$$F$Y$82$KG$20150130$N$LW$US$US
100074805$10007480$5$F$200311$20150113$20140313$20150116$EXP$$US-PFIZER INC-2014066692$PFIZER$$48$YR$$F$Y$$$20150116$N$LW$US$US
100074874$10007487$4$F$201002$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068376$PFIZER$$60$YR$$F$Y$56$KG$20150217$N$LW$US$US
100074894$10007489$4$F$201009$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014069991$PFIZER$$44$YR$$F$Y$$$20150217$N$LW$US$US
100074903$10007490$3$F$200710$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014069934$PFIZER$$55$YR$$F$Y$67$KG$20150202$N$LW$US$US
100075074$10007507$4$F$2007$20150213$20140313$20150223$EXP$$US-PFIZER INC-2014068371$PFIZER$$56$YR$$F$Y$$$20150223$N$LW$US$US
100075163$10007516$3$F$200609$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014068417$PFIZER$$62$YR$$F$Y$100$KG$20150130$N$LW$US$US
100075275$10007527$5$F$2003$20150209$20140313$20150218$EXP$$US-PFIZER INC-2014069951$PFIZER$$49$YR$$F$Y$80$KG$20150218$N$LW$US$US
100075365$10007536$5$F$20050412$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014069892$PFIZER$$56$YR$$F$Y$70$KG$20150130$N$LW$US$US
100075385$10007538$5$F$2006$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014068407$PFIZER$$77$YR$$F$Y$64$KG$20150202$N$LW$US$US
100075474$10007547$4$F$200809$20150209$20140313$20150213$EXP$$US-PFIZER INC-2014068403$PFIZER$$59$YR$$F$Y$$$20150213$N$LW$US$US
100075505$10007550$5$F$2005$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014069937$PFIZER$$62$YR$$F$Y$81$KG$20150202$N$LW$US$US
100075664$10007566$4$F$199907$20150323$20140313$20150326$EXP$$US-PFIZER INC-2014069985$PFIZER$$47$YR$$F$Y$$$20150326$N$LW$US$US
100075674$10007567$4$F$20091001$20150213$20140313$20150223$EXP$$US-PFIZER INC-2014068356$PFIZER$$69$YR$$F$Y$62$KG$20150223$N$LW$US$US
100075724$10007572$4$F$20071105$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068381$PFIZER$$54$YR$$F$Y$$$20150217$N$LW$US$US
100075774$10007577$4$F$200602$20150109$20140313$20150113$EXP$$US-PFIZER INC-2014068370$PFIZER$$63$YR$$F$Y$75$KG$20150113$N$LW$US$US
100075894$10007589$4$F$200011$20150127$20140313$20150129$EXP$$US-PFIZER INC-2014069888$PFIZER$$62$YR$$F$Y$61$KG$20150129$N$LW$US$US
100075945$10007594$5$F$20031208$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014069973$PFIZER$$67$YR$$F$Y$$$20150217$N$LW$US$US
100076014$10007601$4$F$200711$20150226$20140313$20150304$EXP$$US-PFIZER INC-2014069979$PFIZER$$66$YR$$F$Y$$$20150304$N$LW$US$US
100076223$10007622$3$F$20140108$20140224$20140313$20150313$PER$$US-BRACCO-010474$BRACCO$$78$YR$E$M$Y$$$20150313$N$OT$US$US
100079344$10007934$4$F$20140115$20150217$20140313$20150226$EXP$$PHHY2014US018479$SANDOZ$$75$YR$$M$Y$$$20150226$N$OT$US$US
100079834$10007983$4$F$2009$20150209$20140313$20150217$EXP$$US-PFIZER INC-2014068421$PFIZER$$61$YR$$F$Y$111$KG$20150217$N$LW$US$US
100079843$10007984$3$F$201106$20150120$20140313$20150127$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-20386355$BRISTOL MYERS SQUIBB$$65$YR$$F$Y$144$KG$20150127$N$CN$US$US
100080045$10008004$5$F$20140303$20150127$20140313$20150128$EXP$$TR-BAYER-2014-036143$BAYER$$39$YR$A$M$Y$55$KG$20150128$N$MD$TR$TR
100080244$10008024$4$F$201112$20150116$20140313$20150209$EXP$$PHHY2012JP004949$NOVARTIS$$58$YR$$M$Y$$$20150210$N$OT$JP$JP
100080393$10008039$3$F$2013$20150226$20140313$20150306$EXP$$US-PFIZER INC-2014068423$PFIZER$$34$YR$$F$Y$$$20150306$N$LW$US$US
100080405$10008040$5$F$200906$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014069949$PFIZER$$64$YR$$F$Y$78$KG$20150130$N$LW$US$US
100080505$10008050$5$F$2006$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014069972$PFIZER$$57$YR$$F$Y$59$KG$20150130$N$LW$US$US
100080774$10008077$4$F$200603$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014069966$PFIZER$$48$YR$$F$Y$$$20150202$N$LW$US$US
100080825$10008082$5$F$2011$20150127$20140313$20150129$EXP$$US-PFIZER INC-2014066487$PFIZER$$64$YR$$F$Y$$$20150129$N$LW$US$US
100083414$10008341$4$F$$20150210$20140313$20150217$EXP$$US-SANOFI-AVENTIS-2013SA065767$AVENTIS$$57$YR$A$F$Y$$$20150217$N$CN$US$US
100084274$10008427$4$F$20080220$20150127$20140313$20150202$EXP$$US-PFIZER INC-2014069968$PFIZER$$56$YR$$F$Y$106$KG$20150202$N$LW$US$US
100084773$10008477$3$F$20060702$20150127$20140313$20150130$EXP$$US-PFIZER INC-2014069967$PFIZER$$64$YR$$F$Y$72$KG$20150130$N$LW$US$US
100085345$10008534$5$F$1999$20150217$20140313$20150225$EXP$$US-009507513-1403USA004521$MERCK$$$$$F$Y$69.39$KG$20150225$N$CN$US$US
100089032$10008903$2$F$20140224$20150218$20140313$20150225$EXP$SE-MPA-2014-001639$PHHY2014SE027567$SANDOZ$$69$YR$$M$Y$$$20150226$N$OT$SE$SE
100093682$10009368$2$F$$20150306$20140313$20150317$EXP$$SE-TEVA-466246ISR$TEVA$$$$$$Y$$$20150317$N$MD$SE$SE
100101342$10010134$2$F$$20150213$20140312$20150312$PER$$US-INCYTE CORPORATION-2013IN001384$INCYTE$$$$$F$Y$$$20150312$N$MD$US$US
100101662$10010166$2$F$$20140310$20140313$20150211$EXP$$US-GILEAD-2014-0096722$GILEAD$$$$$F$Y$$$20150211$N$CN$US$US
100101702$10010170$2$F$20130725$20150126$20140312$20150312$PER$$US-INCYTE CORPORATION-2013IN001696$INCYTE$$93$YR$$F$Y$$$20150312$N$CN$US$US
100102083$10010208$3$F$201205$20150128$20140313$20150204$EXP$GB-MHRA-EYC00109060$GB-009507513-1403GBR004012$MERCK$$$$$F$Y$$$20150204$N$CN$GB$GB
100103583$10010358$3$F$201210$20150303$20140314$20150312$EXP$SE-MPA-2014-001560$SE-UCBSA-114247$UCB$$62$YR$$F$Y$$$20150310$N$MD$SE$SE
100104845$10010484$5$F$201402$20150205$20140314$20150220$EXP$$AU-BIOGENIDEC-2014BI021196$BIOGEN$$51$YR$$M$Y$$$20150220$N$CN$AU$AU
100106762$10010676$2$F$$20150317$20140314$20150331$EXP$$BE-RANBAXY-2014US-78936$RANBAXY$$58$YR$$M$Y$$$20150331$N$OT$BE$BE
100106883$10010688$3$F$2011$20150109$20140314$20150118$EXP$$US-ASTRAZENECA-2014SE16165$ASTRAZENECA$$63$YR$$F$Y$61.2$KG$20150118$N$CN$US$US
100107483$10010748$3$F$2014$20150201$20140314$20150212$EXP$$US-SA-2014SA031237$AVENTIS$$62$YR$A$M$Y$$$20150212$N$CN$US$US
100107606$10010760$6$F$2014$20150217$20140314$20150226$PER$$US-CELGENEUS-163-21880-14021062$CELGENE$$$$$M$Y$$$20150226$N$OT$US$US
100109694$10010969$4$F$20140227$20140325$20140314$20140407$EXP$$US-SA-2014SA026372$AVENTIS$$57$YR$A$F$Y$$$20140407$N$CN$US$US
100111102$10011110$2$F$$20150114$20140312$20150126$EXP$$KAD201403-000294$KADMON$$60$YR$$M$N$$$20150123$N$OT$JP$
100113192$10011319$2$F$$20140116$20140314$20150227$PER$$US-DRREDDYS-USA/USA/14/0037181$DR REDDYS$$29$YR$$F$Y$$$20150227$N$CN$US$US
100114352$10011435$2$F$$20150119$20140312$20150204$EXP$$2014DE0131$SWEDISH ORPHAN$$$$$M$N$$$20150130$N$OT$DE$
1001145910$10011459$10$F$20130311$20150128$20140314$20150205$EXP$$PHHY2013DE059497$NOVARTIS$$$$E$F$Y$58.5$KG$20150205$N$MD$DE$DE
100116503$10011650$3$F$201305$20140414$20140314$20150310$PER$$US-ENDO PHARMACEUTICALS INC.-OXYC20130032$ENDO$$53$YR$$M$Y$$$20150310$N$CN$US$US
100116602$10011660$2$F$$20140227$20140314$20140314$EXP$$CA-ACTAVIS-2014-04497$WATSON$$$$E$F$Y$$$20140314$N$CN$CA$CA
100118213$10011821$3$F$2010$20150105$20140314$20150108$EXP$$US-PFIZER INC-2014067874$PFIZER$$52$YR$$F$Y$$$20150108$N$LW$US$US
100118655$10011865$5$F$200401$20150209$20140314$20150213$EXP$$US-PFIZER INC-2014068391$PFIZER$$46$YR$$F$Y$$$20150213$N$LW$US$US
100118663$10011866$3$F$200802$20141229$20140314$20150102$EXP$$US-PFIZER INC-2014068422$PFIZER$$40$YR$$F$Y$$$20150102$N$LW$US$US
100118695$10011869$5$F$2009$20150323$20140314$20150327$EXP$$US-PFIZER INC-2014069947$PFIZER$$56$YR$$F$Y$82$KG$20150327$N$LW$US$US
100119042$10011904$2$F$$20140227$20140314$20140314$EXP$$CA-ACTAVIS-2014-04513$ACTAVIS$$$$A$F$Y$$$20140314$N$CN$CA$CA
100119325$10011932$5$F$201402$20150114$20140314$20150120$EXP$$PHHY2014KR023288$NOVARTIS$$55$YR$$F$Y$$$20150120$N$CN$COUNTRY NOT SPECIFIED$KR
100119783$10011978$3$F$20120525$20141225$20140314$20150105$EXP$$JP-SA-THYM-1003858$AVENTIS$$38$YR$A$M$Y$74$KG$20150105$N$MD$JP$JP
100119934$10011993$4$F$20080729$20150127$20140314$20150202$EXP$$US-PFIZER INC-2014068406$PFIZER$$76$YR$$F$Y$$$20150202$N$LW$US$US
100120222$10012022$2$F$$20140227$20140314$20140314$EXP$$CA-ACTAVIS-2014-04643$ACTAVIS$$$$E$F$Y$$$20140314$N$CN$CA$CA
100120312$10012031$2$F$20140224$20150316$20140314$20150319$EXP$$GB-GLAXOSMITHKLINE-B0975657A$GLAXOSMITHKLINE$$69$YR$$F$Y$66.8$KG$20150319$N$MD$GB$GB
100120338$10012033$8$F$$20150116$20140314$20150122$EXP$$US-SA-2013SA107542$AVENTIS$$67$YR$A$F$Y$$$20150122$N$CN$US$US
100120863$10012086$3$F$201401$20150107$20140314$20150113$EXP$$AU-PFIZER INC-2014068932$PFIZER$$72$YR$$F$Y$69.75$KG$20150113$N$MD$AU$AU
100120953$10012095$3$F$2000$20150105$20140312$20150112$EXP$$US-009507513-1403USA002915$MERCK$$$$$F$Y$$$20150112$N$CN$US$US
100122182$10012218$2$F$20140220$20140313$20140314$20150219$PER$$US-ABBVIE-14P-163-1210015-00$ABBVIE$$21$YR$$M$Y$$$20150219$N$MD$COUNTRY NOT SPECIFIED$US
100125018$10012501$8$F$$20150126$20140314$20150210$EXP$$PHEH2014US005155$NOVARTIS$$$$$F$Y$$$20150210$N$CN$COUNTRY NOT SPECIFIED$US
100125133$10012513$3$F$201402$20150205$20140314$20150218$EXP$$CA-BRISTOL-MYERS SQUIBB COMPANY-20400974$BRISTOL MYERS SQUIBB$$78$YR$$M$Y$$$20150218$N$CN$CA$CA
100125252$10012525$2$F$20131028$20140228$20140314$20150128$EXP$$IN-BRISTOL-MYERS SQUIBB COMPANY-20448981$BRISTOL MYERS SQUIBB$$27$YR$$F$Y$$$20150128$N$CN$US$IN
100125553$10012555$3$F$20111228$20150202$20140314$20150210$EXP$$JP-JNJFOC-20140308779$JANSSEN$$68$YR$E$M$Y$79$KG$20150210$N$MD$JP$JP
100126383$10012638$3$F$$20150109$20140314$20150116$EXP$$ES-VERTEX PHARMACEUTICALS INC-2014-001251$VERTEX$$$$$$Y$$$20150116$N$MD$ES$ES
100126542$10012654$2$F$$20150128$20140314$20150210$EXP$$GB-BANPHARM-20142386$BANNER$$13$YR$T$F$Y$50$KG$20150210$N$MD$GB$GB
100127296$10012729$6$F$$20150309$20140314$20150318$EXP$$US-ACTELION-A-NJ2014-95961$ACTELION$$52$YR$A$M$Y$$$20150319$N$OT$US$US
1001273518$10012735$18$F$20130913$20150209$20140314$20150218$EXP$$PHHY2014AU031404$NOVARTIS$$41$YR$$M$Y$$$20150218$N$MD$AU$AU
100128392$10012839$2$F$201205$20150128$20140314$20150205$EXP$GB-MHRA-EYC 00109060$PHHY2014GB027774$SANDOZ$$$$$F$Y$$$20150205$N$CN$GB$GB
100128784$10012878$4$F$20100413$20150109$20140314$20150112$EXP$$FR-ABBVIE-10P-056-0647682-01$ABBVIE$$$$$F$Y$56$KG$20150112$N$MD$COUNTRY NOT SPECIFIED$FR
100128953$10012895$3$F$$20150226$20140314$20150305$PER$$US-PFIZER INC-2012074581$PFIZER$$45$YR$$F$Y$$$20150305$N$CN$US$US
100129224$10012922$4$F$20140128$20150206$20140314$20150212$EXP$$GB-PFIZER INC-2014069563$PFIZER$$56$YR$$M$Y$81.4$KG$20150212$N$MD$GB$GB
100133192$10013319$2$F$$20150114$20140314$20150120$EXP$$US-PFIZER INC-2014074723$PFIZER$$$$$F$Y$$$20150120$N$CN$US$US
100133432$10013343$2$F$$20150217$20140314$20150223$PER$$US-PFIZER INC-2014073917$PFIZER$$71$YR$$F$Y$$$20150223$N$MD$US$US
100133632$10013363$2$F$$20150210$20140314$20150216$PER$$US-PFIZER INC-2014074937$PFIZER$$$$$M$Y$$$20150216$N$CN$US$US
100133784$10013378$4$F$20130501$20150116$20140314$20150122$EXP$$CA-ABBVIE-14P-028-1208292-00$ABBVIE$$47$YR$$F$Y$67.19$KG$20150122$N$MD$COUNTRY NOT SPECIFIED$CA
100135054$10013505$4$F$20131014$20141224$20140314$20150101$EXP$$US-ASTRAZENECA-2014SE17294$ASTRAZENECA$$22928$DY$$M$Y$$$20150101$N$MD$US$US
100137334$10013733$4$F$201005$20150219$20140316$20150225$PER$$US-BAYER-2014-038701$BAYER$$24$YR$A$F$Y$68.27$KG$20150225$N$OT$US$US
100137533$10013753$3$F$201102$20150317$20140316$20150330$EXP$$US-BAYER-2014-039449$BAYER$$23$YR$A$F$Y$88.44$KG$20150330$N$LW$US$US
100138493$10013849$3$F$$20140303$20140316$20140316$EXP$$DE-MYLANLABS-2014S1004791$MYLAN$$$$A$F$Y$$$20140316$N$OT$DE$DE
100138602$10013860$2$F$$20140303$20140316$20140316$EXP$$GB-MYLANLABS-2014S1004883$MYLAN$$25$YR$$F$Y$79$KG$20140316$N$MD$GB$GB
100138722$10013872$2$F$$20140303$20140316$20140316$EXP$$GB-MYLANLABS-2014S1004956$MYLAN$NEWMAN PA, DEO S. NON-TRAUMATIC COMPARTMENT SYNDROME SECONDARY TO DEEP VEIN THROMBOSIS AND ANTICOAGULATION. BMJ-CASE-REP 2014; 2014 [4 PAGES]$57$YR$A$M$Y$$$20140316$N$MD$GB$GB
100139222$10013922$2$F$20131112$20150210$20140316$20150221$PER$$US-JNJFOC-20140308576$MCNEIL$$17$YR$T$F$Y$$$20150221$N$MD$US$US
100140296$10014029$6$F$20131127$20150211$20140317$20150213$EXP$$IT-ROCHE-1365101$ROCHE$$59$YR$$M$Y$75$KG$20150213$N$MD$IT$IT
100140364$10014036$4$F$201401$20150121$20140317$20150126$EXP$$US-009507513-1403USA003949$MERCK$$67$YR$$F$Y$$$20150126$N$MD$US$US
100140553$10014055$3$F$$20150217$20140317$20150224$EXP$$AT-009507513-1304AUT006720$MERCK$$$$$$Y$$$20150224$N$OT$AT$AT
100145422$10014542$2$F$$20150129$20140317$20150210$EXP$$JP-ASTELLAS-2014JP002259$ASTELLAS$TERAKURA S, NISHIDA T, INAMOTO Y, OHASHI H, NAOE T, MURATA M. SUCCESSFUL UNRELATED CORD BLOOD TRANSPLANTATION FOR ADULT ACQUIRED APLASTIC ANEMIA USING REDUCED INTENSITY CONDITIONING WITHOUT ATG. IMMUNOLOGY LETTERS. 2014;160(1):99-101$53$YR$$M$Y$65$KG$20150210$N$CN$JP$JP
100145472$10014547$2$F$$20150129$20140317$20150210$EXP$$JP-ASTELLAS-2014JP002289$ASTELLAS$TERAKURA S, NISHIDA T, INAMOTO Y, OHASHI H, NAOE T, MURATA M. SUCCESSFUL UNRELATED CORD BLOOD TRANSPLANTATION FOR ADULT ACQUIRED APLASTIC ANEMIA USING REDUCED INTENSITY CONDITIONING WITHOUT ATG. IMMUNOLOGY LETTERS. 2014;160(1):99-101$37$YR$$F$Y$51$KG$20150210$N$CN$JP$JP
100146815$10014681$5$F$200912$20141230$20140317$20150105$EXP$$US-PFIZER INC-2014067960$PFIZER$$68$YR$$F$Y$56.69$KG$20150105$N$LW$US$US
100146894$10014689$4$F$20110624$20150212$20140317$20150218$EXP$$US-PFIZER INC-2014068062$PFIZER$$49$YR$$F$Y$$$20150218$N$LW$US$US
100148802$10014880$2$F$$20150205$20140317$20150209$EXP$$GB-PFIZER INC-2014069894$PFIZER$$$$$$Y$$$20150209$N$CN$GB$GB
100149504$10014950$4$F$20140303$20150304$20140317$20150306$EXP$$JP-JNJFOC-20140305457$JANSSEN$$39$YR$A$F$Y$$$20150306$N$MD$JP$JP
100150643$10015064$3$F$20140213$20150108$20140317$20150113$EXP$$PHFR2014GB001488$NOVARTIS$$62$YR$$M$Y$$$20150113$N$MD$GB$GB
100151113$10015111$3$F$$20150223$20140317$20150302$PER$$US-ALEXION PHARMACEUTICALS INC.-A201202974$ALEXION$$$$$$Y$$$20150302$N$CN$US$US
100152394$10015239$4$F$$20150303$20140317$20150313$PER$$US-PFIZER INC-2014073057$PFIZER$$79$YR$$F$Y$$$20150313$N$CN$US$US
100154525$10015452$5$F$20140219$20150319$20140317$20150325$EXP$$KR-SA-2014SA031081$AVENTIS$$28$YR$A$M$Y$89$KG$20150325$N$CN$KR$KR
100154673$10015467$3$F$20130301$20150307$20140317$20150317$EXP$$SE-ASTRAZENECA-2014SE16388$ASTRAZENECA$$79$YR$$F$Y$$$20150317$N$MD$SE$SE
100155963$10015596$3$F$201203$20150102$20140317$20150106$PER$$US-BAYER-2014-038729$BAYER$$26$YR$A$F$Y$57.6$KG$20150106$N$CN$US$US
1001578111$10015781$11$F$20140313$20150310$20140317$20150316$EXP$$US-GLAXOSMITHKLINE-A1059488A$GLAXOSMITHKLINE$$50$YR$$M$Y$$$20150316$N$OT$US$US
100157833$10015783$3$F$201008$20150310$20140317$20150317$PER$$US-BAYER-2014-040357$BAYER$$28$YR$A$F$Y$72.56$KG$20150317$N$CN$US$US
100157845$10015784$5$F$$20141126$20140317$20150129$EXP$$US-GLAXOSMITHKLINE-A1063719A$GLAXOSMITHKLINE$$$$$M$Y$$$20150129$N$CN$US$US
100157902$10015790$2$F$20140116$20150304$20140317$20150313$EXP$$SE-NAPPMUNDI-GBR-2014-0017471$PURDUE$$70$YR$$M$Y$$$20150313$N$MD$SE$SE
100157923$10015792$3$F$201304$20141216$20140317$20150126$PER$$US-CELGENEUS-163-21660-14031057$CELGENE$$56$YR$$F$Y$$$20150126$N$MD$US$US
100158742$10015874$2$F$20140211$20150120$20140317$20150122$EXP$$AU-GLAXOSMITHKLINE-B0969104A$GLAXOSMITHKLINE$$60$YR$$M$Y$71$KG$20150122$N$MD$AU$AU
100159524$10015952$4$F$20140304$20150112$20140317$20150115$EXP$$PHHY2014DE031858$NOVARTIS$$$$A$F$Y$75$KG$20150115$N$MD$DE$DE
100159757$10015975$7$F$2014$20150226$20140317$20150303$EXP$$US-PFIZER INC-2014074274$PFIZER$$54$YR$$F$Y$58$KG$20150303$N$MD$US$US
100161612$10016161$2$F$$20150128$20140317$20150210$EXP$GB-MHRA-EYC 00108845$GB-ACTAVIS-2014-04569$ACTAVIS$$13$YR$$F$Y$50$KG$20150210$N$CN$GB$GB
100163563$10016356$3$F$20130125$20150317$20140317$20150327$EXP$SE-MPA-2014-001864$PHHY2014SE031226$SANDOZ$$74$YR$$M$Y$$$20150327$N$OT$SE$SE
100164274$10016427$4$F$201302$20140508$20140317$20140522$EXP$$GB-ACTAVIS-2014-04599$ACTAVIS$$21$YR$$F$Y$84$KG$20140522$N$CN$GB$GB
100164797$10016479$7$F$2014$20150305$20140317$20150310$EXP$$PHHY2014CA031457$NOVARTIS$$72$YR$$M$Y$$$20150310$N$CN$COUNTRY NOT SPECIFIED$CA
100167674$10016767$4$F$2013$20150210$20140318$20150222$EXP$$PHEH2014US005249$NOVARTIS$$$$$F$Y$$$20150222$N$CN$US$US
100169003$10016900$3$F$$20150108$20140318$20150114$EXP$$HU-BIOGENIDEC-2014BI020828$BIOGEN$$34$YR$A$F$Y$$$20150114$N$OT$HU$HU
100169077$10016907$7$F$2014$20150107$20140318$20150115$EXP$$US-BIOGENIDEC-2014BI023154$BIOGEN$$67$YR$$F$Y$$$20150115$N$CN$US$US
100169126$10016912$6$F$2011$20150127$20140318$20150204$EXP$$US-AMGEN-USASP2013089679$AMGEN$$45$YR$A$F$Y$$$20150204$N$MD$US$US
100169214$10016921$4$F$$20150306$20140318$20150314$EXP$$US-BIOGENIDEC-2014BI023168$BIOGEN$$57$YR$A$F$Y$$$20150314$N$OT$US$US
100171322$10017132$2$F$20150222$20150225$20140318$20150306$EXP$$AR-BRISTOL-MYERS SQUIBB COMPANY-20464418$BRISTOL MYERS SQUIBB$$74$YR$$F$Y$$$20150306$N$CN$AR$AR
100171532$10017153$2$F$$20150309$20140318$20150320$EXP$$US-RANBAXY-2014US-78910$RANBAXY$$56$YR$$F$Y$$$20150320$N$MD$US$US
100172194$10017219$4$F$201303$20150206$20140318$20150219$EXP$$PHHY2014DE031926$NOVARTIS$$$$A$F$Y$$$20150220$N$MD$DE$DE
100172502$10017250$2$F$$20140304$20140318$20150129$EXP$$US-ROCHE-1360444$ROCHE$$$$$M$Y$$$20150129$N$MD$US$US
100173292$10017329$2$F$20140307$20150305$20140318$20150311$EXP$$PHHY2014ZA031642$NOVARTIS$$68$YR$$F$Y$$$20150311$N$OT$ZA$ZA
100174233$10017423$3$F$$20150226$20140318$20150309$PER$$US-PFIZER INC-2014075065$PFIZER$$47$YR$$F$Y$$$20150309$N$MD$US$US
100174713$10017471$3$F$20140227$20140313$20140318$20150326$EXP$$US-ROCHE-1365356$ROCHE$$73$YR$$M$Y$$$20150326$N$MD$US$US
1001749910$10017499$10$F$20140225$20150112$20140318$20150120$EXP$$US-ALEXION-A201400799$ALEXION$$$$$$Y$$$20150120$N$CN$US$US
100176733$10017673$3$F$20121019$20150206$20140318$20150213$PER$$US-ALEXION-A201400643$ALEXION$$$$$$Y$$$20150213$N$CN$US$US
100176782$10017678$2$F$20140204$20150130$20140318$20150205$PER$$US-ALEXION-A201400639$ALEXION$$$$$$Y$$$20150205$N$CN$US$US
100178242$10017824$2$F$$20150202$20140318$20150206$EXP$$JP-ASTELLAS-2014JP002174$ASTELLAS$KADOI E, SHINODA K, TOYOSHIMA Y, NODA M, YASUE S, YOKOYAMA N, ET AL.. A CASE OF DISSEMINATED ASPERGILLOSIS AFTER STEM CELL TRANSPLANTATION. JAPANESE JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY. 2014;51?5?:524-8$13$YR$$F$Y$$$20150206$N$CN$JP$JP
100178525$10017852$5$F$201401$20150127$20140318$20150202$EXP$$NZ-ABBVIE-13P-118-1179964-00$ABBVIE$$58$YR$$F$Y$$$20150202$N$CN$NZ$NZ
100178533$10017853$3$F$20140115$20150217$20140312$20150220$EXP$$ADR-2014-00229$MEDTRONIC$$75$YR$E$M$N$150$LBS$20150218$N$OT$US$
100179372$10017937$2$F$$20150311$20140318$20150318$PER$$US-PFIZER INC-2014078239$PFIZER$$49$YR$$F$Y$$$20150318$N$MD$US$US
100183825$10018382$5$F$2014$20150218$20140318$20150224$EXP$$US-009507513-1403USA005208$MERCK$$33$YR$$M$Y$92.97$KG$20150224$N$CN$US$US
100185782$10018578$2$F$20041127$20141231$20140318$20150108$PER$$US-BAYER-2014-037705$BAYER$$49$YR$A$F$Y$$$20150108$N$CN$US$US
100186365$10018636$5$F$20130401$20150305$20140318$20150309$EXP$$CZ-ROCHE-1225146$ROCHE$$60$YR$$M$Y$71.5$KG$20150309$N$MD$CZ$CZ
100187064$10018706$4$F$20130409$20150121$20140318$20150122$EXP$$GB-ROCHE-1212915$ROCHE$$58$YR$$F$Y$61.8$KG$20150122$N$MD$GB$GB
100188302$10018830$2$F$2004$20150227$20140318$20150309$EXP$$US-PFIZER INC-2014072270$PFIZER$$50$YR$$F$Y$$$20150309$N$LW$US$US
100188522$10018852$2$F$$20150311$20140318$20150326$EXP$$US-PFIZER INC-2014071465$PFIZER$$$$$F$Y$$$20150326$N$LW$US$US
100188792$10018879$2$F$$20140314$20140318$20150327$PER$$US-009507513-1403USA007573$MERCK$$$$A$F$Y$$$20150327$N$CN$US$US
100189084$10018908$4$F$20131221$20150217$20140318$20150304$EXP$$TW-JNJFOC-20140306618$JANSSEN$$88$YR$E$M$Y$$$20150304$N$CN$GB$TW
100189103$10018910$3$F$20140301$20150206$20140318$20150213$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201400820$ALEXION$$$$$$Y$$$20150213$N$CN$US$US
100189263$10018926$3$F$2011$20150116$20140318$20150130$EXP$$US-GLAXOSMITHKLINE-A1064125A$GLAXOSMITHKLINE$$$$$F$Y$$$20150130$N$$COUNTRY NOT SPECIFIED$US
100189813$10018981$3$F$$20150217$20140318$20150220$EXP$$CA-ABBVIE-14P-028-1207923-00$ABBVIE$$$$$F$Y$$$20150220$N$MD$COUNTRY NOT SPECIFIED$CA
100189873$10018987$3$F$20140308$20150122$20140318$20150129$EXP$$JP-GLAXOSMITHKLINE-B0976865A$GLAXOSMITHKLINE$$31$YR$$M$Y$$$20150129$N$CN$JP$JP
100189904$10018990$4$F$20130219$20150218$20140318$20150224$EXP$$JP-GLAXOSMITHKLINE-B0977189A$GLAXOSMITHKLINE$$40$YR$$F$Y$39$KG$20150224$N$CN$JP$JP
100190543$10019054$3$F$20140305$20150311$20140318$20150318$PER$$SE-JNJFOC-20140308856$JANSSEN$$36$YR$A$F$Y$$$20150318$N$OT$SE$SE
100190634$10019063$4$F$2012$20150226$20140318$20150304$EXP$$CA-ABBVIE-12P-028-1029256-00$ABBVIE$$$$$M$Y$83.08$KG$20150304$N$MD$COUNTRY NOT SPECIFIED$CA
100191423$10019142$3$F$$20150319$20140318$20150331$PER$$US-PFIZER INC-2014078304$PFIZER$$86$YR$$F$Y$$$20150331$N$CN$US$US
100191912$10019191$2$F$20131231$20150304$20140318$20150316$EXP$SE-MPA-2014-001735$SE-ELI_LILLY_AND_COMPANY-SE201403003486$ELI LILLY AND CO$$66$YR$$M$Y$$$20150316$N$CN$SE$SE
1001922412$10019224$12$F$$20150109$20140318$20150121$EXP$$US-BAYER-2014-037220$BAYER$$85$YR$E$M$Y$$$20150120$N$OT$US$US
100192252$10019225$2$F$20110730$20150108$20140318$20150112$PER$$US-BAYER-2014-040076$BAYER$$33$YR$A$F$Y$$$20150112$N$LW$US$US
100192385$10019238$5$F$20020806$20150115$20140318$20150128$EXP$$NZ-SA-200217216GDDC$AVENTIS$$38$YR$A$F$Y$73$KG$20150128$N$MD$NZ$NZ
100193502$10019350$2$F$$20150213$20140318$20150224$PER$$US-JNJFOC-20140308116$MCNEIL$$$$A$M$Y$$$20150224$N$MD$US$CA
100193522$10019352$2$F$$20150213$20140318$20150224$PER$$GB-JNJFOC-20140302275$MCNEIL$BATEMAN D, DEAR JW, THANACOODY H, THOMAS SH, EDDLESTON M, SANDILANDS EA, ET AL. REDUCTION OF ADVERSE EFFECTS FROM INTRAVENOUS ACETYLCYSTEINE TREATMENT FOR PARACETAMOL POISONING: A RANDOMISED CONTROLLED TRIAL. THE LANCET 2014 2014;383 (9918):697-704.$$$$$Y$$$20150224$N$MD$GB$GB
100193832$10019383$2$F$2013$20140324$20140318$20150219$PER$$US-ABBVIE-14P-163-1212105-00$ABBVIE$$$$$F$Y$83.54$KG$20150219$N$MD$US$US
100193953$10019395$3$F$20050703$20150128$20140318$20150210$EXP$GB-MHRA-EYC 00109011$GB-ACTAVIS-2014-04827$WATSON$$30$YR$$F$Y$89$KG$20150210$N$CN$GB$GB
100194596$10019459$6$F$20030722$20150226$20140318$20150302$EXP$$US-009507513-1403USA006501$MERCK$$$$$M$Y$104.31$KG$20150302$N$CN$US$US
100195883$10019588$3$F$20140218$20150227$20140318$20150304$EXP$$JP-BAYER-2014-038926$BAYER$$80$YR$E$M$Y$72$KG$20150303$N$MD$JP$JP
100195892$10019589$2$F$20130802$20150109$20140318$20150116$EXP$$US-ENDO PHARMACEUTICALS INC.-FORT20140066$ENDO$$73$YR$$M$Y$77.18$KG$20150116$N$LW$US$US
100198864$10019886$4$F$20131230$20150211$20140318$20150320$PER$$US-GALDERMA-US14000214$GALDERMA$$62$YR$$F$Y$$$20150320$N$CN$US$US
100199732$10019973$2$F$20131210$20150305$20140318$20150313$EXP$SE-MPA-2014-001755$SE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-10927SW$BOEHRINGER INGELHEIM$$80$YR$$F$Y$$$20150313$N$MD$SE$SE
100201402$10020140$2$F$20131129$20150310$20140319$20150323$PER$$SE-JNJFOC-20140306954$MCNEIL$$59$YR$A$F$Y$$$20150323$N$OT$SE$SE
100201515$10020151$5$F$20131228$20150224$20140319$20150302$EXP$$US-AMGEN-USASP2014018053$AMGEN$$8$DY$N$M$Y$$$20150302$N$OT$US$US
100201613$10020161$3$F$201401$20150130$20140319$20150219$EXP$$US-BIOGENIDEC-2014BI023521$BIOGEN$$66$YR$$M$Y$$$20150219$N$MD$US$US
100207822$10020782$2$F$2014$20150303$20140319$20150312$EXP$SE-MPA-2014-001668$SE-ACCORD-022495$ACCORD$$56$YR$$M$Y$$$20150312$N$MD$SE$SE
100208262$10020826$2$F$20140219$20150317$20140319$20150325$EXP$$SE-ASTRAZENECA-2014SE18522$ASTRAZENECA$$82$YR$$M$Y$$$20150325$N$MD$SE$SE
100208762$10020876$2$F$20050703$20150128$20140319$20150211$EXP$$GB-RANBAXY-2014RR-78869$RANBAXY$$$$$$Y$$$20150211$N$OT$GB$GB
100210382$10021038$2$F$20140307$20140310$20140319$20150330$EXP$$US-ASTELLAS-2014US002577$ASTELLAS$$91$YR$$M$Y$$$20150326$N$CN$GB$US
100210964$10021096$4$F$20140321$20150209$20140319$20150216$PER$$US-PFIZER INC-2014075508$PFIZER$$56$YR$$M$Y$115$KG$20150216$N$CN$US$US
100212624$10021262$4$F$20130828$20150111$20140319$20150116$EXP$$US-SA-POMP-1003239$AVENTIS$$61$YR$A$M$Y$$$20150116$N$CN$US$US
100212672$10021267$2$F$$20150327$20140319$20150330$EXP$$DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-11390DE$BOEHRINGER INGELHEIM$$$$$M$Y$$$20150331$N$CN$DE$DE
100212803$10021280$3$F$201310$20150210$20140319$20150219$PER$$US-CELGENEUS-163-21880-14031553$CELGENE$$79$YR$$M$Y$$$20150219$N$MD$US$US
100212835$10021283$5$F$$20150128$20140319$20150203$EXP$$PHHY2014CA031740$NOVARTIS$$$$$M$Y$$$20150203$N$CN$COUNTRY NOT SPECIFIED$CA
100213015$10021301$5$F$20140320$20150220$20140319$20150225$PER$$US-ALEXION-A201400720$ALEXION$$$$$$Y$$$20150225$N$CN$US$US
100213059$10021305$9$F$$20150305$20140319$20150319$EXP$$PHHY2014CA019281$NOVARTIS$$$$$M$Y$$$20150319$N$CN$COUNTRY NOT SPECIFIED$CA
100213834$10021383$4$F$20140206$20150220$20140313$20150303$EXP$$KAD201403-000296$KADMON$$$$$F$N$$$20150302$N$OT$GB$
100214902$10021490$2$F$2012$20150227$20140319$20150306$EXP$$SE-ABBVIE-14P-150-1213953-00$ABBVIE$$75$YR$$M$Y$$$20150306$N$OT$SE$SE
100215392$10021539$2$F$$20140314$20140319$20150305$EXP$$PHHY2014ZA033081$NOVARTIS$$$$A$M$Y$$$20150305$N$CN$COUNTRY NOT SPECIFIED$ZA
100215502$10021550$2$F$20140220$20150305$20140319$20150311$EXP$$SE-SA-2014SA031912$AVENTIS$$72$YR$E$F$Y$$$20150311$N$OT$SE$SE
100216742$10021674$2$F$20140305$20150112$20140319$20150115$EXP$$KR-SA-2014SA030534$AVENTIS$$55$YR$A$M$Y$69$KG$20150115$N$CN$KR$KR
100218862$10021886$2$F$$20140305$20140319$20140319$EXP$DE-BFARM14060109$DE-ACTAVIS-2014-04855$WATSON$$$$A$F$Y$$$20140319$N$CN$DE$DE
100218993$10021899$3$F$201309$20140407$20140319$20150324$EXP$$US-MYLANLABS-2013S1021093$MYLAN$$53$YR$$F$Y$113.4$KG$20150324$N$MD$COUNTRY NOT SPECIFIED$US
100220192$10022019$2$F$2006$20150317$20140319$20150323$EXP$$US-009507513-1403USA005854$MERCK$$$$$F$Y$$$20150323$N$MD$US$US
100220725$10022072$5$F$201408$20150130$20140319$20150203$EXP$$US-GLAXOSMITHKLINE-A1062313A$GLAXOSMITHKLINE$$67$YR$$M$Y$$$20150203$N$CN$US$US
100220964$10022096$4$F$20140207$20150122$20140319$20150127$EXP$$FR-MERCK-1403FRA005950$MERCK$$64$YR$$M$Y$$$20150127$N$CN$FR$FR
100221394$10022139$4$F$$20150227$20140319$20150306$EXP$$US-GLAXOSMITHKLINE-A1065513A$GLAXOSMITHKLINE$$$$$F$Y$$$20150306$N$CN$US$US
100221502$10022150$2$F$201402$20150217$20140319$20150219$EXP$$US-GLAXOSMITHKLINE-A1065635A$GLAXOSMITHKLINE$$57$YR$$F$Y$$$20150219$N$CN$US$US
100224304$10022430$4$F$201104$20150126$20140319$20150129$EXP$$US-PFIZER INC-2014079293$PFIZER$$74$YR$$F$Y$80$KG$20150129$N$CN$US$US
100224603$10022460$3$F$20121219$20150122$20140319$20150128$EXP$$BE-ABBVIE-13P-013-1040929-00$ABBVIE$$57$YR$$F$Y$64$KG$20150128$N$PH$COUNTRY NOT SPECIFIED$BE
100227034$10022703$4$F$20131109$20150312$20140319$20150319$EXP$$FR-PFIZER INC-2014077277$PFIZER$$53$YR$$M$Y$$$20150319$N$OT$FR$FR
100227542$10022754$2$F$$20140306$20140319$20140319$EXP$$US-ACTAVIS-2014-04893$WATSON$VOCKLEY M. SILENT DANGER: OPIOIDS, PCA PUMPS, AND THE CASE FOR CONTINUOUS MONITORING. BIOMED INSTRUM TECHNOL. 2013;47(6):454-65$18$YR$$F$Y$$$20140319$N$OT$US$US
100227643$10022764$3$F$201312$20150204$20140319$20150217$EXP$$PT-JNJFOC-20140310222$JANSSEN$$52$YR$A$F$Y$64$KG$20150217$N$PH$PT$PT
100227832$10022783$2$F$20130115$20150304$20140319$20150319$EXP$SE-MPA-2014-001703$SE-WATSON-2014-04953$WATSON$$41$YR$$F$Y$$$20150319$N$CN$SE$SE
100227862$10022786$2$F$201402$20150325$20140319$20150331$EXP$SE-MPA-2014-001895$SE-PFIZER INC-2014075703$PFIZER$$38$YR$$M$Y$$$20150331$N$MD$SE$SE
100227912$10022791$2$F$20130117$20150306$20140319$20150320$EXP$SE-MPA-2014-001710$SE-WATSON-2014-04956$WATSON$$45$YR$$M$Y$$$20150320$N$CN$SE$SE
100228822$10022882$2$F$$20150224$20140319$20150304$EXP$$US-LUNDBECK-DKLU1098239$LUNDBECK$$$$$F$Y$$$20150304$N$MD$US$US
100229322$10022932$2$F$$20140313$20140319$20150311$PER$$US-SA-2014SA015079$AVENTIS$$64$YR$A$M$Y$$$20150311$N$CN$US$US
100229342$10022934$2$F$201402$20140304$20140319$20150311$PER$$US-SA-2014SA017603$AVENTIS$$$$A$M$Y$$$20150311$N$CN$US$US
100229542$10022954$2$F$$20140221$20140319$20150311$PER$$US-SA-2014SA020733$AVENTIS$$85$YR$E$M$Y$$$20150311$N$CN$US$US
100229592$10022959$2$F$$20140303$20140319$20150311$PER$$US-SA-2014SA021073$AVENTIS$$82$YR$E$M$Y$77$KG$20150311$N$CN$US$US
100229815$10022981$5$F$201311$20150225$20140319$20150309$EXP$$JP-ABBVIE-14P-087-1214429-00$ABBVIE$$30$YR$$M$Y$53.2$KG$20150309$N$MD$COUNTRY NOT SPECIFIED$JP
1002303512$10023035$12$F$201403$20150310$20140319$20150318$EXP$$SE-ALLERGAN-1404703US$ALLERGAN$$50$YR$$M$Y$124$KG$20150318$N$CN$SE$SE
100233334$10023333$4$F$201304$20150302$20140320$20150312$EXP$$CA-ROCHE-1365058$ROCHE$$58$YR$$F$Y$$$20150312$N$MD$CA$CA
1002339310$10023393$10$F$2012$20150309$20140320$20150312$EXP$$CA-ROCHE-1138609$ROCHE$$$$$F$Y$54.4$KG$20150312$N$OT$CA$CA
100235816$10023581$6$F$201402$20150129$20140320$20150205$EXP$$JP-JNJFOC-20140312188$JANSSEN$SAGAWA N, MUKAIJO J, HINOKIDANI M, IKEDA N, UCHIDA T, ICHIYAMA S. A CASE OF DRUG ERUPTION INDUCED BY INFLIXIMAB. 29TH ANNUAL MEETING OF THE JAPANESE SOCIETY FOR PSORIASIS RESEARCH SEP-2014:207.$52$YR$A$F$Y$$$20150205$N$OT$JP$JP
100237412$10023741$2$F$201110$20140306$20140320$20140320$EXP$$GB-MYLANLABS-2014S1005280$MYLAN$$$$$$Y$$$20140320$N$OT$GB$GB
100237762$10023776$2$F$20140201$20140306$20140320$20140320$EXP$IT-MINISAL02-240729$IT-MYLANLABS-2014S1005466$MYLAN$$65$YR$E$M$Y$$$20140320$N$MD$IT$IT
100238432$10023843$2$F$$20140314$20140320$20150327$PER$$US-009507513-1403USA007845$MERCK$$$$E$M$Y$$$20150327$N$CN$US$US
100238563$10023856$3$F$20130527$20150107$20140320$20150112$EXP$$JP-SA-2014SA033634$AVENTIS$$18$YR$A$F$Y$37.2$KG$20150112$N$MD$JP$JP
100238582$10023858$2$F$20140303$20150310$20140320$20150319$EXP$SE-MPA-2014-001856$SE-TEVA-468697ISR$TEVA$$23$YR$$M$Y$$$20150319$N$MD$SE$SE
100239834$10023983$4$F$201501$20150126$20140320$20150202$EXP$$CN-ASTELLAS-2014US002657$ASTELLAS$$61$YR$$M$Y$$$20150202$N$CN$CN$CN
100242672$10024267$2$F$$20150203$20140320$20150206$EXP$$US-PFIZER INC-2014079348$PFIZER$$$$$F$Y$$$20150206$N$CN$US$US
100242962$10024296$2$F$2010$20150303$20140320$20150309$EXP$$SE-ABBVIE-14P-150-1214503-00$ABBVIE$$73$YR$$M$Y$$$20150309$N$OT$SE$SE
100243314$10024331$4$F$201309$20150122$20140131$20150206$EXP$$WIL-001-14-DE$OCTAPHARMA$$31$YR$$F$N$$$20150126$N$MD$DE$
100243343$10024334$3$F$20120318$20150226$20140320$20150306$EXP$$US-PFIZER INC-2014071650$PFIZER$$54$YR$$F$Y$$$20150306$N$LW$US$US
100245892$10024589$2$F$20140307$20150209$20140320$20150211$PER$$US-SHIRE-US201400530$SHIRE$$$$$$Y$$$20150211$N$MD$US$US
100246567$10024656$7$F$20120720$20150304$20140320$20150306$EXP$$US-009507513-1403USA009014$MERCK$$$$$M$Y$154.2$KG$20150306$N$CN$US$US
100249742$10024974$2$F$201402$20150306$20140320$20150317$EXP$SE-MPA-2014-001769$PHHY2014SE029591$SANDOZ$$64$YR$$F$Y$78$KG$20150317$N$OT$SE$SE
100249847$10024984$7$F$20140207$20150303$20140320$20150310$EXP$$US-TEVA-469845USA$TEVA$$19$YR$$F$Y$$$20150310$N$MD$US$US
100250392$10025039$2$F$20130527$20150107$20140320$20150112$EXP$$JP-SA-2014SA033636$AVENTIS$$18$YR$A$F$Y$37.2$KG$20150112$N$MD$JP$JP
100250962$10025096$2$F$20100627$20150317$20140320$20150323$EXP$$SE-PFIZER INC-2014075718$PFIZER$$38$YR$$M$Y$$$20150323$N$MD$SE$SE
100251146$10025114$6$F$20130723$20150108$20140314$20150116$EXP$$2014-US-002763$JAZZ$$67$YR$$M$N$73.4$KG$20150114$N$MD$US$
100251705$10025170$5$F$20110803$20150126$20140320$20150128$EXP$$US-MERCK-1403USA009219$MERCK$$$$$F$Y$48.75$KG$20150128$N$CN$US$US
100252444$10025244$4$F$20140107$20150128$20140218$20150223$EXP$$KAD201401-000111$KADMON$$58$YR$$F$N$$$20150220$N$OT$BR$
100254843$10025484$3$F$2010$20141222$20140320$20150102$PER$$US-ALEXION-A200901382$ALEXION$$$$$$Y$$$20150102$N$CN$US$US
100255232$10025523$2$F$201205$20150128$20140320$20150210$EXP$GB-MHRA-EYC 00109060$GB-WATSON-2014-04966$WATSON$$$$$F$Y$$$20150210$N$CN$GB$GB
100256395$10025639$5$F$201312$20150318$20140320$20150320$EXP$$PHHY2014ZA032873$NOVARTIS$$76$YR$$F$Y$$$20150320$N$MD$ZA$ZA
100257627$10025762$7$F$20140226$20150126$20140314$20150210$EXP$$2014MPI00175$SEATTLE GENETICS$$68$YR$$M$N$63.2$KG$20150206$N$MD$DK$
100258472$10025847$2$F$201403$20150325$20140320$20150331$EXP$SE-MPA-2014-001915$SE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-11592SW$BOEHRINGER INGELHEIM$$58$YR$$M$Y$$$20150331$N$MD$SE$SE
100260043$10026004$3$F$20140227$20150204$20140320$20150211$EXP$$US-ASTRAZENECA-2014SE19089$ASTRAZENECA$$24614$DY$$F$Y$94.3$KG$20150211$N$MD$US$US
100262985$10026298$5$F$20140307$20141219$20140320$20150103$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-20467619$BRISTOL MYERS SQUIBB$$69$YR$$F$Y$100.7$KG$20150103$N$OT$US$US
100267132$10026713$2$F$20140221$20150105$20140321$20150109$EXP$$FR-009507513-1403FRA005843$MERCK$$46$YR$$M$Y$$$20150109$N$OT$FR$FR
100268595$10026859$5$F$20131021$20150116$20140321$20150126$EXP$$CA-ROCHE-1368922$ROCHE$$70$YR$$M$Y$$$20150126$N$CN$CA$CA
100269952$10026995$2$F$201211$20141020$20140321$20150122$EXP$PT-INFARMED-L201302-79$PT-ORION CORPORATION ORION PHARMA-14_00000773$ORION$$67$YR$$M$Y$65$KG$20150122$N$MD$PT$PT
100270133$10027013$3$F$20130325$20140205$20140321$20150326$PER$$US-MYLANLABS-2013S1029171$MYLAN$$64$YR$$M$Y$107.5$KG$20150326$N$OT$US$US
100270174$10027017$4$F$$20150226$20140321$20150305$EXP$$DK-SA-2014SA032248$AVENTIS$$60$YR$A$F$Y$$$20150305$N$MD$DK$DK
100270313$10027031$3$F$$20150212$20140321$20150226$EXP$$HK-JNJFOC-20140308846$MCNEIL$KWAN LP, MOK MM, MA MK, LAM M. ACUTE DRUG TOXICITY RELATED TO DRINKING HERBAL TEA IN A KIDNEY TRANSPLANT RECIPIENT. RENAL FAILURE 2014;36 (2):309-12.$64$YR$A$M$Y$$$20150226$N$OT$HK$CN
100270473$10027047$3$F$20131211$20150226$20140321$20150304$EXP$$US-ABBVIE-14P-163-1213261-00$ABBVIE$$53$YR$$F$Y$68.1$KG$20150304$N$MD$COUNTRY NOT SPECIFIED$US
100272063$10027206$3$F$$20150209$20140321$20150219$EXP$$IT-ALLERGAN-1405249US$ALLERGAN$$56$YR$$F$Y$60$KG$20150219$N$OT$IT$IT
100272102$10027210$2$F$20130331$20150306$20140321$20150317$EXP$$PHHY2014FR031322$SANDOZ$$43$YR$$F$Y$$$20150317$N$OT$FR$FR
100275384$10027538$4$F$20090124$20150209$20140321$20150217$EXP$$US-SANOFI-AVENTIS-2012SA003168$AVENTIS$$80$YR$E$M$Y$$$20150217$N$CN$US$US
100275663$10027566$3$F$$20150212$20140321$20150220$PER$$US-BAYER-2014-042587$BAYER$$21$YR$A$F$Y$69$KG$20150220$N$OT$US$US
100275682$10027568$2$F$$20150114$20140218$20150126$EXP$$KAD201402-000137$KADMON$$57$YR$$M$N$$$20150123$N$OT$BR$
100277095$10027709$5$F$20140305$20150105$20140321$20150107$EXP$$CA-ABBVIE-14P-028-1213301-00$ABBVIE$$85$YR$$M$Y$90.8$KG$20150107$N$MD$COUNTRY NOT SPECIFIED$CA
100277715$10027771$5$F$20140313$20150308$20140321$20150311$EXP$$JP-BAYER-2014-040409$BAYER$$59$YR$A$M$Y$61$KG$20150310$N$MD$JP$JP
100278382$10027838$2$F$$20140307$20140321$20140321$EXP$GB-MHRA-MIDB-4D35472F-D736-4B81-B6E0-A2D025950811$GB-ACTAVIS-2014-05047$ACTAVIS$$48$YR$$M$Y$$$20140321$N$CN$GB$GB
100278542$10027854$2$F$2006$20150303$20140321$20150310$EXP$$US-PFIZER INC-2014064309$PFIZER$$51$YR$$F$Y$$$20150310$N$LW$US$US
1002788328$10027883$28$F$20140316$20150223$20140321$20150303$EXP$$GB-ALEXION PHARMACEUTICALS INC.-A201400647$ALEXION$$$$$$Y$$$20150303$N$CN$GB$GB
100280412$10028041$2$F$20130410$20150306$20140318$20150320$EXP$$2234650$HOSPIRA$$58$YR$$M$N$78.2$KG$20150319$N$MD$GB$
100280963$10028096$3$F$$20150205$20140321$20150211$EXP$$FR-ALEXION PHARMACEUTICALS INC.-A201400865$ALEXION$$$$$$Y$$$20150211$N$CN$FR$FR
100282252$10028225$2$F$$20140311$20140321$20150210$EXP$$GB-ABBVIE-14P-167-1211939-00$ABBVIE$$56$YR$$M$Y$$$20150210$N$CN$GB$GB
100282492$10028249$2$F$$20140307$20140321$20140321$EXP$$DK-ACTAVIS-2014-05349$WATSON$JORNIL J, NIELSEN TS, ROSENDAL I, AHLNER J, ZACKRISSON AL, BOEL LW ET AL. A POOR METABOLIZER OF BOTH CYP2C19 AND CYP2D6 IDENTIFIED BY MECHANISTIC PHARMACOKINETIC SIMULATION IN A FATAL DRUG POISONING CASE INVOLVING VENLAFAXINE. FORENSIC SCI INT. 2013;226 (1-3):E26-31$34$YR$$M$Y$90$KG$20140321$N$OT$DK$DK
100285402$10028540$2$F$201207$20150210$20140321$20150210$EXP$$CA-PFIZER INC-2014080776$PFIZER$BLAIS, A S. COMPLETE PENILE NECROSIS IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA: A CASE REPORT.. UROLOGY CASE REPORTS. 2014;2 (1):21-23$75$YR$$M$Y$$$20150210$N$OT$CA$CA
100286203$10028620$3$F$2013$20150210$20140321$20150218$PER$$US-BAYER-2014-041044$BAYER$$35$YR$A$F$Y$97.96$KG$20150218$N$OT$US$US
100288674$10028867$4$F$2013$20150130$20140321$20150212$EXP$$DE-BRISTOL-MYERS SQUIBB COMPANY-18771535$BRISTOL MYERS SQUIBB$$53$YR$$M$Y$70$KG$20150212$N$CN$DE$DE
100290822$10029082$2$F$201403$20150130$20140321$20150206$EXP$$US-ASTRAZENECA-2014SE18227$ASTRAZENECA$$889$MON$$F$Y$81.2$KG$20150206$N$$US$US
100290942$10029094$2$F$2011$20150223$20140321$20150301$EXP$$ALCN2014TR001747$ALCON$$$$I$M$Y$$$20150302$N$PH$TR$TR
100290968$10029096$8$F$20140221$20150128$20140321$20150204$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201400702$ALEXION$$$$$$Y$$$20150204$N$CN$US$US
100291493$10029149$3$F$20140122$20140313$20140321$20150123$EXP$$BE-BRISTOL-MYERS SQUIBB COMPANY-20093209$BRISTOL MYERS SQUIBB$$62$YR$$M$Y$82.1$KG$20150123$N$OT$BE$BE
100291683$10029168$3$F$20140228$20150205$20140321$20150206$EXP$$DK-ASTRAZENECA-2014SE19639$ASTRAZENECA$$71$YR$$F$Y$$$20150206$N$MD$DE$DE
100292163$10029216$3$F$20130607$20140307$20140321$20140322$EXP$$CZ-SANOFI-AVENTIS-2013SA071860$AVENTIS$$56$YR$A$F$Y$63$KG$20140322$N$MD$CZ$CZ
100292855$10029285$5$F$20120520$20150303$20140321$20150317$EXP$$PHHO2012US007923$NOVARTIS$$76$YR$$F$Y$80.7$KG$20150317$N$MD$US$US
100292862$10029286$2$F$$20140313$20140321$20150217$EXP$$PHHY2014ES034139$NOVARTIS$HIGUERAS JLC, ZAMBONINO MA, MUNOZ C, MAYORGA C, REQUENA G, URDA A, ET AL. TOLERANCE TO COX-2 INHIBITORS IN CHILDREN WITH MULTIPLE HYPERSENSITIVITY TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS.. BRITISH JOURNAL OF DERMATOLOGY. 2014;170:725-729$10$YR$$$Y$$$20150217$N$OT$ES$ES
100295044$10029504$4$F$20140312$20150128$20140322$20150202$EXP$$KR-ROCHE-1367142$ROCHE$$43$YR$$M$Y$68.3$KG$20150202$N$MD$KR$KR
1003100215$10031002$15$F$20140219$20150114$20140324$20150120$EXP$$CA-ROCHE-1367886$ROCHE$$32$YR$$F$Y$$$20150120$N$CN$CA$CA
100310122$10031012$2$F$20140311$20150114$20140324$20150120$EXP$$US-AMGEN-USASP2014019826$AMGEN$$54$YR$A$F$Y$$$20150120$N$OT$US$US
100310383$10031038$3$F$2011$20150220$20140324$20150225$EXP$$US-AMGEN-USASP2014020029$AMGEN$$68$YR$E$F$Y$$$20150225$N$MD$US$US
100312602$10031260$2$F$2012$20150123$20140324$20150128$EXP$$US-AMGEN-USASP2014020018$AMGEN$$76$YR$E$F$Y$$$20150128$N$MD$US$US
100313152$10031315$2$F$$20150102$20140324$20150109$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201102229$ALEXION$$$$$$Y$$$20150109$N$MD$US$US
100313342$10031334$2$F$$20141222$20140324$20150102$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201102213$ALEXION$$$$$$Y$$$20150102$N$CN$US$US
100314442$10031444$2$F$$20150211$20140324$20150218$EXP$$US-ALEXION-A201102246$ALEXION$$$$$F$Y$49$KG$20150218$N$CN$US$US
100315162$10031516$2$F$2011$20150112$20140324$20150121$EXP$$US-ALEXION-A201102238$ALEXION$$$$$$Y$$$20150121$N$CN$US$US
100316122$10031612$2$F$$20150127$20140324$20150129$PER$$US-PFIZER INC-2014081047$PFIZER$$78$YR$$F$Y$$$20150129$N$MD$US$US
100316892$10031689$2$F$$20150305$20140324$20150311$PER$$US-PFIZER INC-2014082352$PFIZER$$$$$M$Y$$$20150311$N$MD$US$US
100317272$10031727$2$F$$20150227$20140324$20150309$PER$$US-PFIZER INC-2014082566$PFIZER$$54$YR$$M$Y$$$20150309$N$MD$US$US
100317824$10031782$4$F$20140226$20150206$20140324$20150210$EXP$$CA-ROCHE-1369367$ROCHE$$83$YR$$F$Y$54.4$KG$20150210$N$MD$CA$CA
100318702$10031870$2$F$$20140310$20140324$20140324$EXP$$US-MYLANLABS-2014S1005853$MYLAN$ATTA MG, STOKES MB. ASN CLINICAL PATHOLOGICAL CONFERENCE. TENOFOVIR-RELATED ATN (SEVERE). C-J-AM-SOC-NEPHROL 2013; 8(5) 882-90$61$YR$A$M$Y$$$20140324$N$MD$US$US
100319772$10031977$2$F$20131003$20150319$20140324$20150331$EXP$$PHHY2014DE032956$NOVARTIS$$$$A$M$Y$$$20150331$N$MD$DE$DE
100321303$10032130$3$F$$20141224$20140324$20150105$EXP$$US-ALEXION-A200700232$ALEXION$$$$$$Y$$$20150105$N$CN$US$US
100321867$10032186$7$F$20131125$20150110$20140324$20150113$EXP$$US-PFIZER INC-2013354060$PFIZER$$62$YR$$F$Y$113.38$KG$20150113$N$OT$US$US
100322003$10032200$3$F$201112$20150305$20140324$20150316$PER$$US-BAYER-2014-043891$BAYER$$24$YR$A$F$Y$63.49$KG$20150316$N$OT$US$US
100322593$10032259$3$F$20140217$20150311$20140324$20150325$EXP$$BG-GLAXOSMITHKLINE-Z0022343A$GLAXOSMITHKLINE$$49$YR$$F$Y$48.6$KG$20150325$N$MD$BG$BG
1003237210$10032372$10$F$201403$20141226$20140324$20150105$EXP$$US-SA-2014SA032878$AVENTIS$$43$YR$A$F$Y$$$20150105$N$CN$US$US
100325894$10032589$4$F$20140305$20150210$20140324$20150212$EXP$$US-TEVA-470325USA$TEVA$$25$YR$$F$Y$$$20150212$N$MD$US$US
100328074$10032807$4$F$201312$20150324$20140324$20150330$EXP$$US-SA-2013SA136268$AVENTIS$$72$YR$E$M$Y$$$20150330$N$CN$US$US
100328758$10032875$8$F$2014$20150306$20140324$20150316$EXP$$US-SA-2014SA009755$AVENTIS$$60$YR$A$F$Y$$$20150316$N$CN$US$US
100329133$10032913$3$F$20130525$20150318$20140324$20150327$EXP$$JP-BAYER-2014-042019$BAYER$$69$YR$E$M$Y$69.39$KG$20150327$N$MD$JP$JP
100329163$10032916$3$F$2005$20150227$20140324$20150306$PER$$US-ALEXION PHARMACEUTICALS INC.-A201102254$ALEXION$$$$$$Y$$$20150306$N$CN$US$US
100329302$10032930$2$F$201109$20150212$20140324$20150219$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201102261$ALEXION$$$$$$Y$$$20150219$N$CN$US$US
100330582$10033058$2$F$$20140311$20140324$20140324$EXP$$CL-SA-2014SA032669$AVENTIS$$55$YR$A$F$Y$$$20140324$N$OT$CL$CL
1003347110$10033471$10$F$2012$20150121$20140325$20150310$EXP$$US-BIOGENIDEC-2014BI025375$BIOGEN$$69$YR$$F$Y$$$20150310$N$MD$US$US
100335905$10033590$5$F$20131128$20150204$20140325$20150218$EXP$$US-BIOGENIDEC-2014BI025985$BIOGEN$$43$YR$A$F$Y$$$20150218$N$MD$US$US
100337612$10033761$2$F$$20140310$20140325$20150306$PER$$US-BIOGENIDEC-2014BI024726$BIOGEN$$61$YR$$F$Y$$$20150306$N$CN$US$US
100337712$10033771$2$F$$20140310$20140325$20150324$PER$$US-BIOGENIDEC-2014BI024784$BIOGEN$$67$YR$$F$Y$$$20150324$N$CN$US$US
100340373$10034037$3$F$2014$20150218$20140325$20150225$PER$$US-009507513-1403USA011212$MERCK$$57$YR$$F$Y$$$20150225$N$OT$US$US
100340882$10034088$2$F$20090729$20150219$20140325$20150223$EXP$$FR-ROCHE-1365154$ROCHE$$$$$F$Y$$$20150223$N$MD$FR$FR
100341302$10034130$2$F$2013$20140416$20140325$20150221$PER$$US-CELGENEUS-163-21880-14032182$CELGENE$$$$$F$Y$48.1$KG$20150221$N$OT$US$US
100343602$10034360$2$F$$20150204$20140325$20150212$EXP$$SG-ELI_LILLY_AND_COMPANY-SG201403008028$ELI LILLY AND CO$$60$YR$$M$Y$$$20150211$N$OT$SG$SG
100344543$10034454$3$F$$20140512$20140321$20150112$EXP$$UTC-045846$UNITED THERAPEUTICS$$37$YR$$F$N$63.2$KG$20150107$N$OT$US$
100344933$10034493$3$F$20070608$20150108$20140325$20150112$PER$$US-BAYER-2014-043155$BAYER$$42$YR$A$F$Y$$$20150112$N$LW$US$US
100345523$10034552$3$F$$20140311$20140325$20140325$EXP$$US-MYLANLABS-2014S1005862$MYLAN$PRESSEY JG, KELLY DR, HAWTHORNE HT. SUCCESSFUL TREATMENT OF PREADOLESCENTS WITH SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE. J-PEDIATR-HEMATOL-ONCOL 2013; 35(7) 566-569$6$YR$C$F$Y$$$20140325$N$MD$US$US
100345722$10034572$2$F$$20140311$20140325$20140325$EXP$$JP-MYLANLABS-2014S1006021$MYLAN$SAKAI T, HATANO Y, ABE I, ISHII K, FUJIWARA S. A CASE OF AN SLE PATIENT WITH FEBRILE NEUTROPENIA WHO EXPERIENCED EXACERBATION OF CUTANEOUS MANIFESTATIONS AFTER THE ADMINISTRATION OF G-CSF. MOD-RHEUMATOL 2013; 23(6) 1231-1236$24$YR$A$F$Y$$$20140325$N$OT$JP$JP
100346545$10034654$5$F$20140221$20150306$20140325$20150316$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201400792$ALEXION$$$$$$Y$$$20150316$N$CN$US$US
100350017$10035001$7$F$20140307$20150319$20140325$20150327$EXP$$CN-ROCHE-1366525$ROCHE$$63$YR$$M$Y$67$KG$20150327$N$MD$CN$CN
100352103$10035210$3$F$2010$20150311$20140325$20150323$PER$$US-BAYER-2014-045125$BAYER$$29$YR$A$F$Y$74.83$KG$20150323$N$OT$US$US
100354012$10035401$2$F$20140115$20150323$20140325$20150327$EXP$$SE-AMGEN-SWESP2014019572$AMGEN$$55$YR$A$F$Y$$$20150327$N$OT$SE$SE
100354767$10035476$7$F$2014$20150210$20140325$20150217$EXP$$US-PFIZER INC-2014082919$PFIZER$$68$YR$$M$Y$$$20150217$N$OT$US$US
100355474$10035547$4$F$2014$20150206$20140325$20150211$EXP$$US-PFIZER INC-2014080884$PFIZER$$73$YR$$M$Y$95.24$KG$20150211$N$CN$US$US
100356064$10035606$4$F$20130820$20150126$20140325$20150128$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12592GD$BOEHRINGER INGELHEIM$TOMITA H,HAGII J,METOKI N,SAITO S,SHIROTO H,OSANAI T,ET AL. SEVERITY AND FUNCTIONAL OUTCOME OF PATIENTS WITH CARDIOEMBOLIC STROKE OCCURRING DURING NOVEL ORAL ANTICOAGULANT TREATMENT. CIRCULATION 2014;130:SUPP2:.$63$YR$$M$Y$65.7$KG$20150128$N$OT$COUNTRY NOT SPECIFIED$JP
100356146$10035614$6$F$20130930$20150126$20140325$20150130$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12762GD$BOEHRINGER INGELHEIM$TOMITA H,HAGII J,METOKI N,SAITO S,SHIROTO H,OSANAI T,ET AL. SEVERITY AND FUNCTIONAL OUTCOME OF PATIENTS WITH CARDIOEMBOLIC STROKE OCCURRING DURING NOVEL ORAL ANTICOAGULANT TREATMENT. CIRCULATION 2014;130:SUPP2:.$75$YR$$F$Y$65$KG$20150130$N$OT$COUNTRY NOT SPECIFIED$JP
100356174$10035617$4$F$20120323$20150126$20140325$20150130$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12765GD$BOEHRINGER INGELHEIM$TOMITA H,HAGII J,METOKI N,SAITO S,SHIROTO H,OSANAI T,ET AL. SEVERITY AND FUNCTIONAL OUTCOME OF PATIENTS WITH CARDIOEMBOLIC STROKE OCCURRING DURING NOVEL ORAL ANTICOAGULANT TREATMENT. CIRCULATION 2014;130:SUPP2:.$88$YR$$F$Y$56$KG$20150130$N$OT$COUNTRY NOT SPECIFIED$JP
100356204$10035620$4$F$20130716$20150126$20140325$20150130$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12586GD$BOEHRINGER INGELHEIM$TOMITA H,HAGII J,METOKI N,SAITO S,SHIROTO H,OSANAI T,ET AL. SEVERITY AND FUNCTIONAL OUTCOME OF PATIENTS WITH CARDIOEMBOLIC STROKE OCCURRING DURING NOVEL ORAL ANTICOAGULANT TREATMENT. CIRCULATION 2014;130:SUPP2:.$69$YR$$M$Y$83$KG$20150130$N$OT$COUNTRY NOT SPECIFIED$JP
100357113$10035711$3$F$20131216$20140314$20140325$20150109$EXP$$IT-VERTEX PHARMACEUTICALS INC-2014-001499$VERTEX$$70$YR$$M$Y$$$20150109$N$OT$IT$IT
100360012$10036001$2$F$20140218$20150311$20140325$20150318$EXP$$DE-TEVA-470496USA$TEVA$$64$YR$$F$Y$$$20150318$N$MD$DE$DE
100360112$10036011$2$F$20140224$20150304$20140325$20150319$EXP$SE-MPA-2014-001802$SE-WATSON-2014-05284$WATSON$$43$YR$$M$Y$$$20150319$N$CN$SE$SE
100360412$10036041$2$F$2014$20140606$20140325$20150223$PER$$US-CELGENEUS-163-21880-14032213$CELGENE$$64$YR$$M$Y$109.8$KG$20150221$N$OT$US$US
100361529$10036152$9$F$20140226$20150313$20140325$20150318$EXP$$CL-OTSUKA-US-2014-10440$OTSUKA$$$$$$Y$$$20150318$N$MD$CL$CL
100362095$10036209$5$F$201209$20150210$20140325$20150211$EXP$$GB-PFIZER INC-2014082949$PFIZER$$74$YR$$F$Y$$$20150211$N$MD$GB$GB
100362194$10036219$4$F$20140217$20150115$20140325$20150127$PER$$US-CELGENEUS-163-21880-14022900$CELGENE$$82$YR$$F$Y$62.65$KG$20150127$N$MD$US$US
100364282$10036428$2$F$$20140319$20140325$20150123$PER$$US-009507513-1403USA010038$MERCK$$$$$$Y$$$20150123$N$PH$US$US
100364713$10036471$3$F$20120612$20150108$20140326$20150109$EXP$$IT-ROCHE-1078220$ROCHE$$66$YR$$F$Y$43.5$KG$20150109$N$MD$IT$IT
100364824$10036482$4$F$20130325$20150323$20140326$20150330$EXP$$AU-ROCHE-1209213$ROCHE$$62$YR$$F$Y$77$KG$20150330$N$MD$AU$AU
100365083$10036508$3$F$$20140519$20140325$20140526$EXP$$PHEH2014US005853$NOVARTIS$$$$$M$Y$$$20140526$N$MD$US$US
100365322$10036532$2$F$201001$20150326$20140326$20150330$EXP$$FR-ROCHE-1367480$ROCHE$$78$YR$$F$Y$$$20150330$N$MD$FR$FR
100365833$10036583$3$F$20020101$20150119$20140326$20150128$EXP$$US-BIOGENIDEC-2014BI026789$BIOGEN$$55$YR$$F$Y$$$20150128$N$CN$US$US
100367672$10036767$2$F$20140310$20140311$20140326$20150319$PER$$US-BIOGENIDEC-2014BI024846$BIOGEN$$61$YR$$F$Y$$$20150319$N$CN$US$US
100370976$10037097$6$F$20140317$20141230$20140326$20150102$EXP$$DK-ROCHE-1367885$ROCHE$$69$YR$$M$Y$74.3$KG$20150102$N$MD$DK$DK
100371436$10037143$6$F$20140305$20150102$20140326$20150108$EXP$$US-AMGEN-USASP2014017008$AMGEN$$21$YR$A$F$Y$$$20150108$N$CN$US$US
100372333$10037233$3$F$2013$20150219$20140326$20150225$EXP$$CA-AMGEN-CANSP2013050982$AMGEN$$80$YR$E$F$Y$$$20150224$N$OT$CA$CA
100372583$10037258$3$F$20060922$20150128$20140326$20150205$PER$$US-BAYER-2014-044871$BAYER$$39$YR$A$F$Y$90.7$KG$20150205$N$OT$US$US
100373853$10037385$3$F$2012$20150202$20140326$20150217$EXP$$GB-ACCORD-022755$ACCORD$$72$YR$$F$Y$64.3$KG$20150217$N$CN$GB$GB
100375942$10037594$2$F$20131121$20150211$20140324$20150226$EXP$$UTC-045925$UNITED THERAPEUTICS$$73$YR$$M$N$$$20150219$N$OT$US$
100376232$10037623$2$F$2014$20150218$20140324$20150302$EXP$$UTC-045961$UNITED THERAPEUTICS$$45$YR$$F$N$78.92$KG$20150226$N$$US$
100378243$10037824$3$F$20090821$20150203$20140326$20150210$EXP$$SG-SA-2014SA036385$AVENTIS$$34$YR$A$M$Y$114$KG$20150210$N$MD$SG$TH
100378395$10037839$5$F$201212$20150210$20140326$20150210$EXP$$US-PFIZER INC-2013358086$PFIZER$$59$YR$$M$Y$85$KG$20150210$N$CN$US$US
100378522$10037852$2$F$201001$20150130$20140326$20150209$PER$$US-BAYER-2014-043186$BAYER$$20$YR$A$F$Y$74.83$KG$20150209$N$CN$US$US
100379844$10037984$4$F$201304$20150203$20140326$20150206$EXP$$JP-SA-2014SA023805$AVENTIS$MABUCHI S, YOSHIKAWA K, TAKAHASHI H, MASUDA T, TAKAHASHI M, ISOTANI E. A CASE OF CALCIUM CHANNEL BLOCKER INTOXICATION. KANTO JOURNAL OF JAPANESE ASSOCIATION FOR ACUTE MEDICINE. 2014;35(2):329-31.$69$YR$E$F$Y$$$20150206$N$OT$JP$JP
100380512$10038051$2$F$2011$20150226$20140326$20150305$EXP$$FR-TEVA-471015ISR$TEVA$$$$$F$Y$$$20150305$N$CN$FR$FR
100383702$10038370$2$F$$20150312$20140326$20150320$PER$$US-TEVA-471335USA$TEVA$$$$$F$Y$$$20150320$N$CN$US$US
100384465$10038446$5$F$20140102$20150213$20140326$20150224$EXP$$ES-GLAXOSMITHKLINE-B0971823A$GLAXOSMITHKLINE$$70$YR$$M$Y$87$KG$20150223$N$MD$ES$ES
100384876$10038487$6$F$201402$20150204$20140326$20150209$EXP$$JP-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12053NB$BOEHRINGER INGELHEIM$$74$YR$$M$Y$65.2$KG$20150209$N$MD$JP$JP
100385084$10038508$4$F$20020704$20141231$20140326$20150106$EXP$$US-PFIZER INC-2014079326$PFIZER$$43$YR$$F$Y$81.63$KG$20150106$N$LW$US$US
100386864$10038686$4$F$201312$20150120$20140326$20150127$EXP$$BR-ABBVIE-14P-020-1214292-00$ABBVIE$$54$YR$$M$Y$95$KG$20150127$N$CN$COUNTRY NOT SPECIFIED$BR
100387703$10038770$3$F$20140313$20150304$20140326$20150306$EXP$$US-ACTELION-A-CH2014-96380$ACTELION$$73$YR$E$F$Y$59.1$KG$20150306$N$OT$US$US
100388652$10038865$2$F$20140212$20150119$20140326$20150122$EXP$$IT-VERTEX PHARMACEUTICALS INC-2014-001462$VERTEX$$49$YR$$M$Y$83$KG$20150122$N$MD$IT$IT
100389996$10038999$6$F$$20140513$20140326$20150313$EXP$GB-PFIZER INC-2014074487$GB-BRISTOL-MYERS SQUIBB COMPANY-20546982$BRISTOL MYERS SQUIBB$$$$$F$Y$$$20150313$N$CN$IN$GB
100390852$10039085$2$F$201211$20141020$20140326$20150123$EXP$$PHHY2014PT034601$NOVARTIS$$68$YR$$M$Y$65$KG$20150123$N$OT$PT$PT
100391572$10039157$2$F$20130201$20150122$20140326$20150205$EXP$$PHHY2014JP033812$NOVARTIS$$57$YR$$M$Y$50$KG$20150205$N$MD$JP$JP
100392443$10039244$3$F$20140207$20140320$20140325$20140325$EXP$$PHHO2014GB002183$NOVARTIS$$$$$$Y$$$20140325$N$MD$GB$GB
100393762$10039376$2$F$20131204$20150107$20140326$20150115$EXP$$PHHY2014DE035210$NOVARTIS$$$$$M$Y$3$KG$20150115$N$OT$DE$DE
100395312$10039531$2$F$$20140306$20140326$20150209$EXP$$PHHY2014NL036613$NOVARTIS$$$$A$F$Y$$$20150210$N$CN$COUNTRY NOT SPECIFIED$NL
100395505$10039550$5$F$20130224$20150202$20140326$20150209$EXP$$FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2014-BI-12821BY$BOEHRINGER INGELHEIM$GONZVA J, PATRICELLI R,LIGNAC D. SPONTANEUS SPLENIC RUPTURE IN A PATIENT TREATED WITH RIVAROXABAN. AMERICAN JOURNAL OF EMERGENCY MEDICINE 2014;1.$67$YR$$M$Y$50$KG$20150210$N$OT$COUNTRY NOT SPECIFIED$FR
100396754$10039675$4$F$201310$20150220$20140326$20150224$EXP$$VE-ABBVIE-14P-178-1215878-00$ABBVIE$$60$YR$$F$Y$$$20150223$N$CN$VE$VE
100400842$10040084$2$F$20140225$20150113$20140326$20150119$PER$$US-009507513-1403USA002672$MERCK$$73$YR$$F$Y$43.84$KG$20150119$N$CN$US$US
100401803$10040180$3$F$20130903$20150123$20140326$20150128$PER$$US-CELGENEUS-163-21880-13092594$CELGENE$$79$YR$$M$Y$$$20150128$N$MD$US$US
100402232$10040223$2$F$$20150105$20140327$20150119$EXP$$US-RANBAXY-2014US-79235$RANBAXY$SHROBA JA, CHOJNACKI K. VIRAL INDUCED IBUPROFEN SENSITIVITY LEADING TO ANAPHYLAXIS IN PRESCHOOL AGED CHILDREN. J ALLERGY CLIN IMMUNOL. 2014;133(2):230$$$C$$Y$$$20150119$N$OT$US$US
100402242$10040224$2$F$$20150105$20140327$20150119$EXP$$US-RANBAXY-2014US-79233$RANBAXY$SHROBA JA, CHOJNACKI K. VIRAL INDUCED IBUPROFEN SENSITIVITY LEADING TO ANAPHYLAXIS IN PRESCHOOL AGED CHILDREN. J ALLERGY CLIN IMMUNOL. 2014;133(2):230$$$C$$Y$$$20150119$N$OT$US$US
100402252$10040225$2$F$$20150105$20140327$20150119$EXP$$US-RANBAXY-2014US-79207$RANBAXY$SHROBA JA, CHOJNACKI K. VIRAL INDUCED IBUPROFEN SENSITIVITY LEADING TO ANAPHYLAXIS IN PRESCHOOL AGED CHILDREN. J ALLERGY CLIN IMMUNOL. 2014;133(2):230$$$C$$Y$$$20150119$N$OT$US$US
100402553$10040255$3$F$20131126$20150313$20140327$20150323$EXP$$FR-AMGEN-FRASP2014020478$AMGEN$$53$YR$A$M$Y$$$20150322$N$OT$FR$FR
100403413$10040341$3$F$201403$20150306$20140327$20150314$EXP$$US-BIOGENIDEC-2014BI023203$BIOGEN$$53$YR$$M$Y$86$KG$20150314$N$MD$US$US
100404534$10040453$4$F$201310$20150112$20140327$20150121$EXP$$TR-AMGEN-TURSP2014013405$AMGEN$$58$YR$A$F$Y$93$KG$20150121$N$CN$TR$TR
100406063$10040606$3$F$2011$20150211$20140327$20150213$EXP$$CH-BAYER-2014-045279$BAYER$$33$YR$A$F$Y$$$20150213$N$MD$CH$CH
100408123$10040812$3$F$20131216$20150107$20140327$20150109$EXP$$IT-VERTEX PHARMACEUTICALS INC-2014-001596$VERTEX$$57$YR$$M$Y$$$20150109$N$OT$IT$IT
100408743$10040874$3$F$201402$20150218$20140327$20150226$EXP$$US-PFIZER INC-2014083846$PFIZER$$50$YR$$M$Y$$$20150226$N$OT$US$US
100409542$10040954$2$F$$20150204$20140327$20150213$PER$$US-PFIZER INC-2014086124$PFIZER$$$$$F$Y$$$20150213$N$CN$US$US
100410933$10041093$3$F$$20150203$20140327$20150210$EXP$$US-ASTELLAS-2014US002938$ASTELLAS$$$$$M$Y$$$20150210$N$CN$US$US
100411153$10041115$3$F$20150218$20150304$20140327$20150310$EXP$$PHHY2014CA036265$NOVARTIS$$59$YR$$F$Y$$$20150310$N$CN$COUNTRY NOT SPECIFIED$CA
100411262$10041126$2$F$2014$20150112$20140327$20150116$PER$$US-009507513-1403USA006635$MERCK$$$$$F$Y$60.32$KG$20150116$N$CN$US$US
100415445$10041544$5$F$20121225$20150109$20140327$20150119$EXP$$CA-ABBVIE-13P-028-1096623-00$ABBVIE$$66$YR$$F$Y$68$KG$20150119$N$MD$COUNTRY NOT SPECIFIED$CA
100415852$10041585$2$F$$20150121$20140327$20150130$PER$$US-PFIZER INC-2014084763$PFIZER$$50$YR$$M$Y$$$20150130$N$MD$US$US
100417079$10041707$9$F$$20150323$20140327$20150330$EXP$$US-SANOFI-AVENTIS-2013SA019970$AVENTIS$$57$YR$A$F$Y$$$20150330$N$CN$US$US
100417652$10041765$2$F$20130125$20150317$20140327$20150331$EXP$SE-MPA-2014-001864$SE-WATSON-2014-05487$WATSON$$74$YR$$M$Y$$$20150331$N$CN$SE$SE
100420139$10042013$9$F$20131017$20150107$20140327$20150129$EXP$$US-BRISTOL-MYERS SQUIBB COMPANY-20243598$BRISTOL MYERS SQUIBB$$61$YR$A$M$Y$$$20150129$N$CN$US$US
100421622$10042162$2$F$201401$20150317$20140327$20150325$EXP$$SE-ASTRAZENECA-2014SE19218$ASTRAZENECA$$44$YR$$F$Y$$$20150325$N$MD$SE$SE
100422293$10042229$3$F$20131028$20141224$20140327$20150313$EXP$$IL-GLAXOSMITHKLINE-B0978933B$GLAXOSMITHKLINE$$72$YR$$M$Y$$$20150313$N$MD$IL$IL
100422323$10042232$3$F$20120726$20150306$20140327$20150310$EXP$$JP-GLAXOSMITHKLINE-B0979243A$GLAXOSMITHKLINE$$69$YR$$F$Y$64$KG$20150310$N$CN$JP$JP
100422333$10042233$3$F$20120917$20150306$20140327$20150310$EXP$$JP-GLAXOSMITHKLINE-B0979244A$GLAXOSMITHKLINE$$53$YR$$M$Y$63$KG$20150310$N$CN$JP$JP
100423272$10042327$2$F$20140224$20150225$20140327$20150304$EXP$$IE-AMGEN-IRLSP2014020810$AMGEN$$58$YR$A$F$Y$40$KG$20150304$N$MD$IE$IE
100423733$10042373$3$F$20130404$20150115$20140327$20150119$EXP$$US-009507513-1403USA012012$MERCK$$$$$F$Y$$$20150119$N$MD$US$US
100423992$10042399$2$F$20140227$20150227$20140327$20150306$EXP$$US-SA-2014SA036551$AVENTIS$$62$YR$A$F$Y$$$20150306$N$CN$US$US
100424433$10042443$3$F$2014$20140417$20140327$20150311$EXP$$CA-UCBSA-114639$UCB$$35$YR$$F$Y$44$KG$20150310$N$OT$CA$CA
100425443$10042544$3$F$$20140402$20140327$20150302$PER$$US-ABBVIE-13P-163-1115382-00$ABBVIE$$$$$F$Y$62.65$KG$20150302$N$MD$US$US
100426843$10042684$3$F$$20140314$20140327$20140327$EXP$$CA-MYLANLABS-2014S1006370$MYLAN$HATEGAN A, BOURGEOIS JA, PARTHASARATHI U. ACUTE COLONIC PSEUDO-OBSTRUCTION (OGILVIE SYNDROME) IN PROGRESSIVE SUPRANUCLEAR PALSY. PSYCHOSOMATICS 2013; 54(1) 80-83$74$YR$E$F$Y$$$20140327$N$MD$CA$CA
100426872$10042687$2$F$$20140314$20140327$20140327$EXP$$GB-MYLANLABS-2014S1006289$MYLAN$BLACKBURN DJ, ALIX JJ, SARRIGIANNIS P, HOGGARD N, BANDMANN O. DELAYED TOXIC-HYPOXIC ENCEPHALOPATHY. PRACT-NEUROL 2013; 13(2) 114-9$37$YR$A$M$Y$$$20140327$N$MD$GB$GB
100426916$10042691$6$F$20131106$20150225$20140327$20150302$EXP$$PHFR2013GB006309$NOVARTIS$$38$YR$$F$Y$$$20150302$N$OT$GB$GB
100427362$10042736$2$F$$20140326$20140327$20150122$EXP$$PHHY2014AR037535$NOVARTIS$$$$$M$Y$$$20150122$N$CN$COUNTRY NOT SPECIFIED$AR
100427754$10042775$4$F$2001$20150130$20140327$20150204$EXP$$US-009507513-1403USA012657$MERCK$$$$$M$Y$143.76$KG$20150204$N$MD$US$US
100429452$10042945$2$F$$20150120$20140328$20150127$EXP$$US-ROCHE-1370874$ROCHE$$$$$F$Y$105.33$KG$20150127$N$CN$US$US
100429584$10042958$4$F$$20150224$20140328$20150227$EXP$$CA-AMGEN-CANSP2014020423$AMGEN$$66$YR$E$F$Y$59$KG$20150227$N$CN$CA$CA
100429815$10042981$5$F$$20150106$20140328$20150108$EXP$$US-ROCHE-635591$ROCHE$, DAVIS R, RAWAL S, NASTOUPIL L, HAGEMEISTER F, MCLAUGHLIN P, KWAK L, ROMAGUERA J, FANALE M, FAYAD L, WESTIN J, SHAH J, ORLOWSKI R, WANG M, TURTURRO F, OKI Y, C CLARET L, FENG L, BALADANDAYUTHAPANI V, MUZZAFAR T, Y TSAI K, SAMANIEGO F,ET AL SAFETY AND ACTIVITY OF LENALIDOMIDE AND RITUXIMAB IN UNTREATED INDOLENT LYMPHOMA: AN OPEN-LABEL, PHASE 2 TRIAL. THE LANCET ONCOLOGY 2014 NOV 01;15(12):1311-1318.$$$$$Y$$$20150108$N$MD$US$US
100430122$10043012$2$F$201403$20150107$20140328$20150119$EXP$$BR-BIOGENIDEC-2013BI122966$BIOGEN$$33$YR$$F$Y$$$20150119$N$CN$BR$BR
100431365$10043136$5$F$20140120$20150319$20140328$20150319$EXP$$US-AMGEN-USASP2013071506$AMGEN$$30$YR$A$F$Y$104.31$KG$20150319$N$MD$US$US
100432826$10043282$6$F$20140224$20150202$20140328$20150206$EXP$$PHHY2014CA032168$NOVARTIS$$74$YR$$M$Y$$$20150206$N$CN$COUNTRY NOT SPECIFIED$CA
100434614$10043461$4$F$201403$20150303$20140328$20150311$PER$$US-PFIZER INC-2014085147$PFIZER$$71$YR$$M$Y$90.7$KG$20150311$N$MD$US$US
100434863$10043486$3$F$$20150113$20140328$20150123$EXP$$DE-AMGEN-DEUSP2014022182$AMGEN$$42$YR$A$F$Y$$$20150123$N$CN$DE$DE
100436044$10043604$4$F$20140123$20150311$20140328$20150323$EXP$$JP-JNJFOC-20140314931$JANSSEN$ITO J. FOUR CASES OF TRIPLE THERAPY WITH SIMEPREVIR SODIUM IN PATIENTS WITH POST-LIVER TRANSPLANT CHRONIC HEPATITIS C. 2015;59.$64$YR$A$F$Y$39$KG$20150323$N$MD$JP$JP
100436073$10043607$3$F$20140310$20150202$20140328$20150217$EXP$$JP-JNJFOC-20140314935$JANSSEN$KATSUYOSHI T, AKIHIKO O. SIMEPREVIR WITH PEGINTERFERON AND RIBAVIRIN INDUCED INTERSTITIAL PNEUMONITIS: FIRST CASE REPORT. WORLD JOURNAL OF GASTROENTEROLOGY 21-JAN-2015;21(3):1009-1013.$70$YR$E$F$Y$$$20150217$N$MD$JP$JP
100437474$10043747$4$F$20131127$20150212$20140328$20150217$EXP$$PT-ROCHE-1371143$ROCHE$$72$YR$$M$Y$75$KG$20150217$N$MD$PT$PT
100438353$10043835$3$F$20120627$20150210$20140328$20150213$PER$$JP-SA-THYM-1003857$AVENTIS$$51$YR$A$M$Y$61$KG$20150213$N$MD$JP$JP
100442016$10044201$6$F$201309$20150326$20140328$20150331$EXP$$US-ROCHE-1277849$ROCHE$$2$DY$$M$Y$2.72$KG$20150331$N$MD$US$US
100442403$10044240$3$F$2013$20150121$20140328$20150130$EXP$$CA-ABBVIE-14P-028-1192126-00$ABBVIE$$$$$M$Y$$$20150130$N$MD$COUNTRY NOT SPECIFIED$CA
100442822$10044282$2$F$$20150305$20140328$20150312$EXP$$CA-JNJFOC-20140315703$JANSSEN$$$$A$F$Y$99.79$KG$20150312$N$CN$CA$CA
100443532$10044353$2$F$2012$20150210$20140326$20150218$EXP$$2014080776$PFIZER$$75$YR$$M$N$$$20150210$N$OT$CA$
100444106$10044410$6$F$20140319$20150224$20140328$20150303$EXP$$CA-JNJFOC-20140306113$JANSSEN$$66$YR$E$F$Y$101$KG$20150303$N$CN$CA$CA
100445523$10044552$3$F$20140207$20150121$20140328$20150130$EXP$$KR-PFIZER INC-2014086305$PFIZER$$63$YR$$M$Y$$$20150130$N$MD$KR$KR
100446314$10044631$4$F$20130918$20140314$20140328$20140328$EXP$$GB-MYLANLABS-2014S1006432$MYLAN$$32$YR$$M$Y$82.8$KG$20140328$N$PH$GB$GB
100449584$10044958$4$F$20130327$20150209$20140328$20150213$EXP$$US-PFIZER INC-2014088572$PFIZER$$78$YR$$F$Y$$$20150213$N$LW$US$US
100450346$10045034$6$F$20140128$20141224$20140328$20150105$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201400952$ALEXION$$$$$$Y$$$20150105$N$CN$US$US
100451973$10045197$3$F$$20150219$20140328$20150226$EXP$$US-ALEXION PHARMACEUTICALS INC.-A201001957$ALEXION$$$$$$Y$$$20150226$N$CN$US$US
100452405$10045240$5$F$20140222$20150204$20140328$20150220$EXP$$IT-WATSON-2014-05617$WATSON$$66$YR$$M$Y$$$20150220$N$CN$IT$IT
100454403$10045440$3$F$20140316$20150310$20140328$20150320$EXP$$US-TARO-2014P1002732$TARO$$79$YR$$M$Y$70$KG$20150320$N$MD$US$US
100454715$10045471$5$F$2000$20150220$20140328$20150225$EXP$$US-009507513-1403USA011500$MERCK$$$$$M$Y$94.33$KG$20150225$N$MD$US$US
100455805$10045580$5$F$2013$20150204$20140328$20150210$EXP$$US-PFIZER INC-2014087273$PFIZER$$41$YR$$M$Y$$$20150210$N$CN$US$US
100458784$10045878$4$F$20140213$20150119$20140329$20150119$EXP$$JP-ROCHE-1368121$ROCHE$WATANABE R, TAKAHASHI HIROHARU, ISHIMURA ATSUNORI 58 A PATIENT WHO UNDERWENT EMERGENCY DIALYSIS FOR SUSPECTED ACUTE RENAL DISORDER DUE TO OSELTAMIVIR PHOSPHATE AND CLARITHROMYCIN. //; ABSTRACTS OF THE 305TH ANNUAL KYUSHU REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE/ THE 305TH ANNUAL KYUSHU REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE (31 MAY 2014)/ KUMAMOTO-SHI, KUMAMOTO()/() ;:-.$65$YR$$F$Y$69$KG$20150119$N$MD$JP$JP
100462762$10046276$2$F$20140216$20140317$20140331$20150320$PER$$US-BIOGENIDEC-2014BI026741$BIOGEN$$48$YR$$F$Y$$$20150320$N$CN$US$US
100469024$10046902$4$F$20130410$20150115$20140331$20150126$PER$$US-BAYER-2014-048259$BAYER$$50$YR$A$F$Y$64.85$KG$20150126$N$CN$US$US
100469454$10046945$4$F$20140307$20150123$20140331$20150203$EXP$$US-CREALTA PHARMACEUTICALS-2014S1000019$CREALTA$$77$YR$$F$Y$126.03$KG$20150202$N$$COUNTRY NOT SPECIFIED$US
100469475$10046947$5$F$20140228$20150127$20140331$20150203$EXP$$US-ALEXION-A201400868$ALEXION$$$$$$Y$$$20150203$N$CN$US$US
100469922$10046992$2$F$20130925$20150325$20140331$20150329$EXP$$PHHY2014IN038315$NOVARTIS$$$$E$M$Y$$$20150329$N$CN$COUNTRY NOT SPECIFIED$IN
100472802$10047280$2$F$201311$20140403$20140331$20150330$PER$$US-MYLANLABS-2013S1027512$MYLAN$$62$YR$$F$Y$$$20150330$N$CN$US$US
100473842$10047384$2$F$20131101$20141223$20140331$20150107$EXP$$RU-VERTEX PHARMACEUTICALS INC-2014-001602$VERTEX$$57$YR$$M$Y$70$KG$20150107$N$MD$RU$RU
100474363$10047436$3$F$20140320$20141120$20140331$20150129$EXP$$IE-ASTELLAS-2014US003135$ASTELLAS$$76$YR$$M$Y$$$20150129$N$CN$GB$IE
100475622$10047562$2$F$$20140317$20140331$20140331$EXP$$US-MYLANLABS-2014S1006526$MYLAN$OPPENHEIMER AP, KOH C, MCLAUGHLIN M, WILLIAMSON JC, NORTON TD, LAUDADIO J, ET AL. VANISHING BILE DUCT SYNDROME IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED ADULTS: A REPORT OF TWO CASES. WORLD-J-GASTROENTEROL 2013; 19(1) 115-121$41$YR$A$M$Y$$$20140331$N$OT$US$US
100475633$10047563$3$F$20090218$20141224$20140331$20150105$EXP$$GB-TEVA-191675ISR$TEVA$$66$YR$$F$Y$$$20150105$N$MD$GB$GB
100475754$10047575$4$F$2005$20150213$20140331$20150223$EXP$$US-PFIZER INC-2014088510$PFIZER$$56$YR$$F$Y$68$KG$20150223$N$LW$US$US
100475835$10047583$5$F$1999$20150227$20140331$20150309$EXP$$US-PFIZER INC-2014090127$PFIZER$$66$YR$$F$Y$$$20150309$N$LW$US$US
100475996$10047599$6$F$200701$20150223$20140331$20150225$EXP$$US-009507513-1205USA02804$MERCK$$$$$M$Y$105.67$KG$20150225$N$OT$US$US
100476253$10047625$3$F$$20150105$20140331$20150106$EXP$$US-PFIZER INC-2014090317$PFIZER$$39$YR$$F$Y$59$KG$20150106$N$MD$US$US
